10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 26, 2020

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _____

Commission File Number 001-38635

Resideo Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware	82-5318796
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
901 E 6th Street Austin, Texas	78702
(Address of principal executive offices)	(Zip Code)

(512) 726-3500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	Trading Symbol:	Name of each exchange on which registered:
Common Stock, par value $0.001 per share	REZI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the Registrant’s common stock, par value $0.001 per share, as of November 2, 2020 was 123,494,919 shares.

TABLE OF CONTENTS

	Item		Page
Part I.		Item 1. Financial Statements	5
	1.	Financial Statements	5
		Consolidated Interim Statements of Operations (unaudited) – Three and Nine Months Ended September 26, 2020 and September 28, 2019	5
		Consolidated Interim Statements of Comprehensive Income (Loss) (unaudited) – Three and Nine Months Ended September 26, 2020 and September 28, 2019	6
		Consolidated Interim Balance Sheets (unaudited) – September 26, 2020 and December 31, 2019	7
		Consolidated Interim Statements of Cash Flows (unaudited) – Nine Months Ended September 26, 2020 and September 28, 2019	8
		Consolidated Interim Statements of Equity (unaudited) – Three and Nine Months Ended September 26, 2020 and September 28, 2019	9
		Notes to Consolidated Interim Financial Statements (unaudited)	10
	2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
	3.	Quantitative and Qualitative Disclosures About Market Risk	34
	4.	Controls and Procedures	35
Part II.	1.	Legal Proceedings	36
	1A.	Risk Factors	36
	6.	Exhibits	39
		Signatures	40

2

RESIDEO TECHNOLOGIES, INC.

Cautionary Statement about Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains “forward-looking statements” that involve risks and uncertainties. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections about our industries and our business and financial results. Forward-looking statements often include words such as “anticipates,” “estimates,” “expects,” “projects,” “forecasts,” “intends,” “plans,” “continues,” “believes,” “may,” “will,” “goals” and words and terms of similar substance in connection with discussions of future operating or financial performance. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. Our actual results may vary materially from those expressed or implied in our forward-looking statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by us or on our behalf. Although we believe that the forward-looking statements contained in this Form 10-Q are based on reasonable assumptions, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those in such forward-looking statements, including but not limited to:

• the level of competition from other companies in our markets and segments, as well as in new markets and emerging markets;

• ability to successfully develop new technologies and introduce new products;

• integration and retention of new leadership personnel, including the CEO and CFO;

• inability to recruit and retain qualified personnel;

• changes in prevailing global and regional economic conditions;

• natural disasters or inclement or hazardous weather conditions, including, but not limited to cold weather, flooding, tornadoes and the physical impacts of climate change;

• the impact of pandemics, epidemics and other public health emergencies, such as COVID-19;

• fluctuation in financial results due to seasonal nature of portions of our business;

• failure to achieve and maintain a high level of product and service quality;

• dependence upon investment in information technology;

• failure or inability to comply with relevant data privacy legislation or regulations, including the European Union’s General Data Protection Regulation and the California Consumer Privacy Act;

• technical difficulties or failures;

• work stoppages, other disruptions, or the need to relocate any of our facilities;

• economic, political, regulatory, foreign exchange and other risks of international operations, including the impact of tariffs;

• changes in legislation or government regulations or policies;

• our growth strategy is dependent on expanding our distribution business;

• inability to obtain necessary product components, production equipment or replacement parts;

• the significant failure or inability to comply with the specifications and manufacturing requirements of our original equipment manufacturers (“OEMs”) customers;

• inability to implement and execute actions to achieve the expected results from our financial and operational review initially disclosed in connection with our 2019 third-quarter results;

• the possibility that our goodwill or intangible assets become impaired;

• increases or decreases to the inventory levels maintained by our customers;

• difficulty collecting receivables;

• the failure to protect our intellectual property or allegations that we have infringed the intellectual property of others;

• our inability to maintain intellectual property agreements;

• our inability to service our indebtedness;

• the failure to increase productivity through sustainable operational improvements;

• inability to grow successfully through future acquisitions;

• the operational constraints and financial distress of third parties;

• changes in the price and availability of raw materials that we use to produce our products;

3

RESIDEO TECHNOLOGIES, INC.

• labor disputes;

• our ability to borrow funds and access capital markets;

• the amount of our obligations and nature of our contractual restrictions pursuant to, and disputes that have or may hereafter arise under, the Reimbursement Agreement and the other agreements we entered into with Honeywell in connection with the Spin-Off;

• our reliance on Honeywell for the Honeywell Home trademark;

• potential material environmental liabilities;

• our inability to fully comply with data privacy laws and regulations;

• potential material losses and costs as a result of warranty claims, including product recalls, and product liability actions that may be brought against us;

• potential business and other disruption due to cyber security threats or concerns;

• potential material litigation matters;

• unforeseen U.S. federal income tax and foreign tax liabilities;

• U.S. federal income tax reform;

• the inception or suspension in the future of any dividend program; and

• certain factors discussed elsewhere in this Form 10-Q.

These and other factors are more fully discussed in our filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” section in our 2019 Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Annual Report on Form 10-K”) and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section in this Form 10-Q. There have been no material changes to the risk factors described in our 2019 Annual Report on Form 10-K, except as reflected in the “Risk Factors” section in this Form 10-Q. These risks could cause actual results to differ materially from those implied by forward-looking statements in this Form 10-Q. Even if our results of operations, financial condition and liquidity and the development of the industries in which we operate are consistent with the forward-looking statements contained in this Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods.

Any forward-looking statements made by us in this Form 10-Q speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

PART I

The financial statements and related footnotes as of September 26, 2020 should be read in conjunction with the financial statements for the year ended December 31, 2019 contained in our 2019 Annual Report on Form 10-K.

4

RESIDEO TECHNOLOGIES, INC.

Item 1. Financial Statements

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS

(Dollars in millions except share and per share data)

(Unaudited)

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net revenue	$	1,362	$	1,226	$	3,570		$	3,684
Cost of goods sold		992		917		2,680			2,720
Gross profit		370		309		890			964
Selling, general and administrative expenses		239		250		731			778
Operating profit		131		59		159			186
Other expense, net		35		35		106			54
Interest expense		14		16		49			51
Income before taxes		82		8		4			81
Tax expense		7		-		26			36
Net income (loss)	$	75	$	8	$	(22	)	$	45
Weighted Average Number of Common Shares Outstanding (in thousands)
Basic		123,421		122,770		123,194			122,681
Diluted		125,235		123,244		123,194			123,404
Earnings (Loss) Per Share
Basic	$	0.61	$	0.07	$	(0.18	)	$	0.37
Diluted	$	0.60	$	0.06	$	(0.18	)	$	0.36

The unaudited Notes to Consolidated Interim Financial Statements are an integral part of these statements.

5

RESIDEO TECHNOLOGIES, INC.

CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Dollars in millions)

(Unaudited)

	Three Months Ended					Nine Months Ended
	September 26,		September 28,			September 26,			September 28,
	2020		2019			2020			2019
Net income (loss)	$	75	$	8		$	(22	)	$	45
Other comprehensive income (loss), net of tax
Foreign exchange translation adjustment		28		(35	)		6			(33	)
Total other comprehensive income (loss), net of tax		28		(35	)		6			(33	)
Comprehensive income (loss)	$	103	$	(27	)	$	(16	)	$	12

The unaudited Notes to Consolidated Interim Financial Statements are an integral part of these statements.

6

RESIDEO TECHNOLOGIES, INC.

CONSOLIDATED INTERIM BALANCE SHEETS

(Dollars in millions, shares in thousands)

(Unaudited)

	September 26,			December 31,
	2020			2019
ASSETS
Current assets:
Cash and cash equivalents	$	260		$	122
Accounts receivable – net		884			817
Inventories – net		618			671
Other current assets		161			175
Total current assets		1,923			1,785
Property, plant and equipment – net		311			316
Goodwill		2,657			2,642
Other assets		378			385
Total assets	$	5,269		$	5,128
LIABILITIES
Current liabilities:
Accounts payable	$	858		$	920
Current maturities of debt		181			22
Accrued liabilities		606			552
Total current liabilities		1,645			1,494
Long-term debt		1,141			1,158
Obligations payable under Indemnification Agreements		586			594
Other liabilities		292			280
COMMITMENTS AND CONTINGENCIES (Note 13)
EQUITY
Common stock, $0.001 par value, 700,000 shares authorized, 124,324 and 123,443 shares issued and outstanding as of September 26, 2020, 123,488 and 122,873 shares issued and outstanding as of December 31, 2019, respectively		-			-
Additional paid-in capital		1,782			1,761
Treasury stock, at cost		(5	)		(3	)
Retained earnings		16			38
Accumulated other comprehensive (loss)		(188	)		(194	)
Total equity		1,605			1,602
Total liabilities and equity	$	5,269		$	5,128

The unaudited Notes to Consolidated Interim Financial Statements are an integral part of these statements.

7

RESIDEO TECHNOLOGIES, INC.

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Dollars in millions)

(Unaudited)

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Cash flows provided by (used for) operating activities:
Net (loss) income	$	(22	)	$	45
Adjustments to reconcile net (loss) income to net cash provided by (used for) operating activities:
Depreciation and amortization		64			55
Restructuring charges, net of payments		4			12
Stock compensation expense		21			22
Other		20			10
Changes in assets and liabilities:
Accounts receivable		(64	)		(27	)
Inventories – net		64			(109	)
Other current assets		15			(13	)
Accounts payable		(62	)		(23	)
Accrued liabilities		48			(6	)
Obligations payable under Indemnification Agreements		(8	)		(49	)
Other		12			13
Net cash provided by (used for) operating activities		92			(70	)
Cash flows used for investing activities:
Expenditures for property, plant, equipment and other intangibles		(50	)		(66	)
Cash paid for acquisitions, net of cash acquired		(35	)		(17	)
Net cash used for investing activities		(85	)		(83	)
Cash flows provided by financing activities:
Net proceeds from revolving credit facility		150			60
Repayment of long-term debt		(11	)		(11	)
Non-operating obligations paid to Honeywell, net		(2	)		(24	)
Tax payments related to stock vestings		(2	)		(3	)
Net cash provided by financing activities		135			22
Effect of foreign exchange rate changes on cash and cash equivalents		(4	)		(2	)
Net increase (decrease) in cash and cash equivalents		138			(133	)
Cash and cash equivalents at beginning of period		122			265
Cash and cash equivalents at end of period	$	260		$	132

The unaudited Notes to Consolidated Interim Financial Statements are an integral part of these statements.

8

RESIDEO TECHNOLOGIES, INC.

CONSOLIDATED INTERIM STATEMENTS OF EQUITY

(Dollars in millions, shares in thousands)

(Unaudited)

Three Months Ended September 26, 2020	Common Shares		Treasury Shares		Common Stock		Treasury Stock			Additional Paid- In Capital		Retained Earnings (Deficit)			Accumulated Other Comprehensive Loss			Total Equity
Balance at June 27, 2020		123,378		852	$	-	$	(5	)	$	1,775	$	(59	)	$	(216	)	$	1,495
Net income		-		-		-		-			-		75			-			75
Other comprehensive income, net of tax		-		-		-		-			-		-			28			28
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes		65		29		-		-			-		-			-			-
Stock-based compensation		-		-		-		-			7		-			-			7
Balance at September 26, 2020		123,443		881	$	-	$	(5	)	$	1,782	$	16		$	(188	)	$	1,605
Three Months Ended September 28, 2019	Common Shares		Treasury Shares		Common Stock		Treasury Stock			Additional Paid- In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total Equity
Balance at June 29, 2019		122,710		558	$	-	$	(2	)	$	1,743	$	39		$	(187	)	$	1,593
Net income		-		-		-		-			-		8			-			8
Other comprehensive loss, net of tax		-		-		-		-			-		-			(35	)		(35	)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes		76		38		-		(1	)		-		-			-			(1	)
Stock-based compensation		-		-		-		-			8		-			-			8
Balance at September 28, 2019		122,786		596	$	-	$	(3	)	$	1,751	$	47		$	(222	)	$	1,573
Nine Months Ended September 26, 2020	Common Shares		Treasury Shares		Common Stock		Treasury Stock			Additional Paid- In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total Equity
Balance at December 31, 2019		122,873		615	$	-	$	(3	)	$	1,761	$	38		$	(194	)	$	1,602
Net loss		-		-		-		-			-		(22	)		-			(22	)
Other comprehensive income, net of tax		-		-		-		-			-		-			6			6
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes		570		266		-		(2	)		-		-			-			(2	)
Stock-based compensation	-		-			-					21		-		-				21
Balance at September 26, 2020		123,443		881	$	-	$	(5	)	$	1,782	$	16		$	(188	)	$	1,605
Nine Months Ended September 28, 2019	Common Shares		Treasury Shares		Common Stock		Treasury Stock			Additional Paid- In Capital		Retained Earnings			Accumulated Other Comprehensive Loss			Total Equity
Balance at December 31, 2018		122,499		468	$	-	$	-		$	1,720	$	2		$	(189	)	$	1,533
Net income		-		-		-		-			-		45			-			45
Other comprehensive loss, net of tax		-		-		-		-			-		-			(33	)		(33	)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes		287		128		-		(3	)		-		-			-			(3	)
Stock-based compensation	-		-			-		-			22		-		-				22
Adjustments due to Spin-Off		-		-		-		-			9		-			-			9
Balance at September 28, 2019		122,786		596	$	-	$	(3	)	$	1,751	$	47		$	(222	)	$	1,573

The unaudited Notes to Consolidated Interim Financial Statements are an integral part of these statements.

9

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Dollars in millions, unless otherwise noted)

(Unaudited)

Note 1. Organization, Operations and Basis of Presentation

Business Description

Resideo Technologies, Inc. (“Resideo” or “the Company”), is a global provider of products, software, solutions and technologies that help homeowners stay connected and in control of their comfort, security and energy use. The Company is a leader in the home heating, ventilation and air conditioning controls and security markets, and a leading global distributor of low-voltage electronic and security products.

The Company was incorporated in Delaware on April 24, 2018. The Company separated from Honeywell International Inc. (“Honeywell”) on October 29, 2018, becoming an independent publicly traded company as a result of a pro rata distribution of the Company’s common stock to shareholders of Honeywell (the “Spin-Off”).

Basis of Presentation

The Company’s financial statements are presented on a consolidated basis (collectively, the “Interim Financial Statements”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany transactions have been eliminated for all periods presented. The Interim Financial Statements are unaudited; however, in the opinion of management, they contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

In periods subsequent to the Spin-Off, we have made adjustments to balances transferred at the Spin-Off, including adjustments to the classification of assets or liabilities transferred. Any such adjustments are recorded directly to equity in Adjustments due to the Spin-Off and are considered immaterial.

The Company reports financial information on a fiscal quarter basis using a “modified” 4-4-5 calendar (modified in that the fiscal year always begins on January 1 and ends on December 31) that requires its businesses to close their first, second and third quarter books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. In the event that differences in closing dates are material to year-over-year comparisons of quarterly or year-to-date results, the Company will provide appropriate disclosures.

Reclassification 

On January 1, 2020, the Company changed its classification of research and development expenses in the Consolidated Interim Statements of Operations from Cost of goods sold to Selling, general and administrative expenses, such that research and development expenses are excluded from the calculation of Gross profit. The impact on the September 28, 2019 Consolidated Interim Statement of Operations is a reduction of Cost of goods sold, an increase in Gross profit and an increase in Selling, general and administrative expenses for the three and nine months ended September 28, 2019 of $20 million and $66 million, respectively. The impact of the reclassification for the three and nine months ended September 28, 2019 is also reflected in “Note 6. Restructuring and Other Charges”. This reclassification had no effect on the previously reported Net income (loss) or the Company’s Consolidated Interim Statements of Comprehensive Income (Loss), Consolidated Interim Statements of Cash Flows, or Consolidated Interim Balance Sheets.

10

Note 2. Summary of Significant Accounting Policies

The Company’s accounting policies are set forth in “Note 2. Summary of Significant Accounting Policies” of the Company’s Notes to Consolidated and Combined Financial Statements included in the 2019 Annual Report on Form 10-K. Included herein are certain updates to those policies.

The World Health Organization (“WHO”) declared the novel coronavirus disease ("COVID-19") a pandemic in March 2020. Starting at the end of the first quarter and throughout the second quarter, the Company experienced constrained supply and slowed customer demand that adversely impacted the Company’s business, results of operations and overall financial performance. Although there remains uncertainty as to the continuing implications of COVID-19, during the third quarter customer demand improved and cost actions taken during the first half of the year contributed to improvements in the Company’s results of operations and overall financial performance. As there remains uncertainty around the impacts of the COVID-19 pandemic, the Company addresses and evaluates the impacts frequently. At September 26, 2020, the Company believes that the accounting policies most likely to be affected by the COVID-19 pandemic are the following:

Use of Estimates—The preparation of the Company’s Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the Consolidated Financial Statements and related disclosures in the accompanying Notes to Consolidated Financial Statements. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed, and the effects of changes are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Estimates are used when accounting for stock-based compensation, pension benefits, contingent consideration, indemnification liabilities, goodwill and intangible assets, and valuation allowances for accounts receivable, inventory, deferred tax assets, and the amounts of revenue and expenses reported during the period. The Company has used information available to identify potential impacts caused by the COVID-19 pandemic at September 26, 2020 in these estimates.

Goodwill— The Company has determined that it is likely that the carrying value of goodwill exceeds the fair value at September 26, 2020. However, the extent to which COVID-19 may adversely impact our business depends on future developments, which are uncertain and unpredictable, depending upon the severity and duration of the outbreak, and the effectiveness of actions taken globally to contain or mitigate its effects. Any resulting financial impact cannot be estimated reasonably at this time but may adversely affect our business and financial results. It is likely that, during the remainder of 2020 and into 2021, macroeconomic conditions will be volatile and could impact our business. If there is an adverse change in facts and circumstances, then an impairment charge may be necessary in the future. Specifically, the fair value of our Products & Solutions reporting unit, with goodwill of approximately $2,012 million at September 26, 2020, exceeded its' carrying value by 10% in the 2019 annual impairment test and therefore is highly sensitive to adverse changes in the facts and circumstances that could result in a possible future impairment. Should the fair value of the Company’s reporting units fall below its' carrying amount because of reduced operating performance, market declines, changes in the discount rate, a more significant impact than expected from the COVID-19 pandemic, or other conditions, charges for impairment may be necessary. The Company regularly monitors its reporting units to determine if there is an indicator of potential impairment. The Company will perform its annual goodwill impairment assessment during the fourth quarter.

Recent Accounting Pronouncements—The Company considers the applicability and impact of all recent accounting standards updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial position or results of operations.

In August 2018, the FASB issued guidance that amends the current disclosure requirements regarding defined benefit pensions and other post retirement plans and allows for the removal of certain disclosures, while adding certain new disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2020 and allows for early adoption. The Company will adopt on January 1, 2021 and does not expect this new standard to have a significant impact to its disclosures.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by, among other things, eliminating certain existing exceptions related to the general approach in ASC 740 relating to franchise taxes, reducing complexity in

11

the interim-period accounting for year-to-date loss limitations and changes in tax laws, and clarifying the accounting for transactions outside of business combinations that result in a step-up in the tax basis of goodwill. The transition requirements are primarily prospective and the effective date for Resideo is January 1, 2021, with early adoption permitted. The Company early adopted the provisions of this guidance on January 1, 2020. Adoption of this guidance did not have a material financial statement impact.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which is optional guidance related to reference rate reform that provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our Term Loans and Revolving Credit Facility, which use LIBOR as a reference rate, and is effective immediately, but is only available through December 31, 2022. Refer to “Note 10. Long-term Debt and Credit Agreement” for further details on our Term Loans and Revolving Credit Facility. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

Note 3. Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in millions except shares in thousands and per share data):

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Shares used in computing basic earnings per share		123,421		122,770		123,194			122,681
Effect of dilutive securities:
Dilutive effect of common stock equivalents		1,814		474		-			723
Shares used in computing diluted earnings per share		125,235		123,244		123,194			123,404
Earnings (loss) per share:
Basic	$	0.61	$	0.07	$	(0.18	)	$	0.37
Diluted	$	0.60	$	0.06	$	(0.18	)	$	0.36

Diluted earnings per share is computed based upon the weighted average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the three and nine months ended September 26, 2020 and September 28, 2019. In periods where the Company has a net loss, no dilutive common shares are included in the calculation for diluted shares as they are considered anti-dilutive. For the three and nine months ended September 26, 2020, average options and other rights to purchase approximately 1.1 million and 3.6 million shares of common stock, respectively, were outstanding, all of which were anti-dilutive during the three and nine months ended September 26, 2020, and therefore excluded from the computation of diluted earnings per common share. In addition, an average of approximately 0.8 million and 0.6 million shares of performance-based unit awards are excluded from the computation of diluted earnings per common share for the three and nine months ended September 26, 2020 as the contingency has not been satisfied. For the three and nine months ended September 28, 2019, options and other rights to purchase approximately 3.8 million and 1.5 million shares of common stock, respectively, were outstanding, all of which were anti-dilutive during the three and nine months ended September 28, 2019, and therefore excluded from the computation of diluted income per common share. An average of approximately 0.3 million shares of performance-based unit awards are excluded from the computation of diluted earnings per common share for the three and nine months ended September 28, 2019, as the contingency has not been satisfied.

12

Note 4. Acquisitions

On February 10, 2020, the Company completed the acquisition of privately held Herman ProAV, a leading provider and distributer of professional audio-visual products, procurement services and labor resources to systems integrators in the commercial audio-visual industry. The purchase price paid for this acquisition was approximately $36 million. In connection with this acquisition, the Company recognized goodwill and intangible assets of $4 million and $18 million, respectively. This acquisition was integrated into and builds upon ADI Global Distribution’s product portfolio and expands its presence in the pro-AV market. The Herman ProAV acquisition agreements include deferred payments for certain individuals that are contingent upon employment as well as financial performance. The Company determined that these deferred payments are accounted for as compensation expense over the requisite service period. The Company is substantially complete with the allocation of purchase price, however, amounts are still subject to finalization. Pro-forma disclosures are not provided as the acquisition has an immaterial financial statement impact.

Note 5. Revenue Recognition

Disaggregated Revenue

Revenues by geography and business line are as follows:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Comfort	$	297	$	256	$	725	$	799
Security		142		128		379		397
Residential Thermal Solutions		133		128		341		404
Products & Solutions		572		512		1,445		1,600
U.S. and Canada		650		590		1,758		1,705
EMEA (1)		129		109		338		336
APAC (2)		11		15		29		43
ADI Global Distribution		790		714		2,125		2,084
Net revenue	$	1,362	$	1,226	$	3,570	$	3,684

(1) EMEA represents Europe, the Middle East and Africa.

(2) APAC represents Asia and Pacific countries.

The Company recognizes the majority of its revenue from performance obligations outlined in contracts with its customers that are satisfied at a point in time. Approximately 3% of the Company’s revenue is satisfied over time. As of September 26, 2020 and September 28, 2019, contract assets and liabilities were not material. 

Note 6. Restructuring and Other Charges

During the fourth quarter of 2019, the Company announced commencement of a comprehensive financial and operational review focused on product cost, gross margin improvement, and general and administrative expense simplification. The review is being overseen by the Strategic and Operational Committee of the board, comprised of independent directors. The Company retained industry-recognized experts in supply chain optimization and organizational excellence to assist in the review. Certain restructuring actions have been and are continuing to be implemented under this program as well as previous programs. Products & Solutions segment restructuring and related expenses for the three and nine months ended September 26, 2020 were $7 million and $24 million, respectively, and for the three and nine months ended September 28, 2019, restructuring and related expense were $9 million and $28 million, respectively. ADI Global Distribution segment restructuring and related expenses for the three and nine months ended September 26, 2020 were $0 million and $3 million, respectively, and for the three and nine months ended September 28, 2019, restructuring and related expenses were $0 million and $6 million, respectively. Restructuring and related expenses for all periods are primarily related to severance.

13

The Company's restructuring expenses for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	2	$	4	$	7	$	11
Selling, general and administrative expenses		5		5		20		23
	$	7	$	9	$	27	$	34

The following table summarizes the status of total restructuring reserves related to severance cost included in Accrued liabilities in the unaudited Consolidated Balance Sheets: 

	Nine Months Ended
	September 26,
	2020
Beginning of period	$	19
Charges		27
Usage – cash payments		(23	)
End of period	$	23

Note 7. Income Taxes

The Company recorded a tax expense of $7 million and $26 million for the three and nine months ended September 26, 2020, respectively.

For interim periods, income tax is equal to the total of (1) year-to-date pretax income multiplied by our forecasted effective tax rate plus (2) tax expense items specific to the period. In situations where we expect to report losses for which we do not expect to receive tax benefits, we are required to apply separate forecasted effective tax rates to those jurisdictions rather than including them in the consolidated forecasted effective tax rate.

For the three months ended September 26, 2020, the net tax expense of $7 million was driven by interim period tax expense of $7 million based on year-to-date actual amounts. Tax expense specific to the period was $0. In addition to items specific to the period, our income tax rate is impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

For the nine months ended September 26, 2020, net tax expense of $26 million consisted primarily of interim period tax expense of $11 million based on year-to-date actual amounts, and tax expense specific to the period of approximately $15 million, consisting primarily of $15 million for valuation allowances in foreign jurisdictions, $2 million related to the estimated tax impact of the CARES Act on prior years, and share-based excess cost of $1 million, partially offset by a $3 million tax benefit for changes in estimates related to prior years. In addition to items specific to the period, our income tax rate is impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

Note 8. Inventories—Net

	September 26,			December 31,
	2020			2019
Raw materials	$	156		$	154
Work in process		20			18
Finished products		521			568
Inventory reserves		(79	)		(69	)
	$	618		$	671

14

Note 9. Accrued Liabilities

	September 26,		December 31,
	2020		2019
Obligations payable under Indemnification Agreements	$	175	$	140
Taxes payable		53		66
Compensation, benefit and other employee-related		82		66
Customer rebate reserve		71		78
Other		225		202
	$	606	$	552

Refer to “Note 13. Commitments and Contingencies” for further details on Obligations payable under Indemnification Agreements.

Note 10. Long-term Debt and Credit Agreement

The Company’s debt at September 26, 2020 and December 31, 2019 consisted of the following:

	September 26,			December 31,
	2020			2019
6.125% notes due 2026	$	400		$	400
Five-year variable rate term loan A due 2023		324			333
Seven-year variable rate term loan B due 2025		468			470
Revolving Credit Facility		150			-
Unamortized deferred financing costs and debt discounts		(20	)		(23	)
Total outstanding indebtedness		1,322			1,180
Less: amounts due within one year		181			22
Total long-term debt due after one year	$	1,141		$	1,158

On November 26, 2019, the Company entered into a First Amendment to the Credit Agreement (the “Credit Agreement Amendment”). The Credit Agreement Amendment amended the five-year variable rate term loan A due 2023 (the “Term A Loan Facility”), the seven-year variable rate term loan B due 2025 (the “Term B Loan Facility” and together, the “Term Loans”) and the five-year senior secured first-lien revolving credit facility (the “Revolving Credit Facility”) credit agreement (the “Credit Agreement”) to, among other things: (i) increase the levels of the maximum consolidated total leverage ratio under the Credit Agreement, to not greater than 5.25 to 1.00 for the quarter ended December 31, 2019, with step-downs to 4.75 to 1.00 starting in the quarter ending December 31, 2020, 4.25 to 1.00 starting in the quarter ending December 31, 2021, and 3.75 to 1.00 starting in the quarter ending December 31, 2022; (ii) increase each applicable interest rate margin on loans outstanding after the Credit Agreement Amendment effective date by 25 basis points per annum, 2.25% per annum (for LIBOR loans) and 1.25% per annum (for ABR loans) in respect of the Term B Loan Facility, and based on our leverage ratio, from 2.25% per annum to 1.75% per annum (for LIBOR loans) and 1.25% to 0.75% per annum (for ABR loans) for the Term A Loan Facility and the Revolving Credit Facility; and (iii) modify the defined terms “Consolidated EBITDA” and “Pro Forma Basis” set forth in the Credit Agreement.

As of September 26, 2020, there were $150 million of borrowings and no letters of credit issued under the Revolving Credit Facility. The Company assessed the amount recorded under the Term Loans, the 6.125% senior unsecured notes (the “Senior Notes”), and the Revolving Credit Facility. The Company determined that the Revolving Credit Facility approximated fair value. The Term A Loan Facility, Term B Loan Facility and the Senior Notes’ fair values are approximately $307, $460 and $395 million, respectively. The fair values of the debt are based on the quoted inactive prices and are therefore classified as Level 2 within the valuation hierarchy.

At September 26, 2020, the interest rate for the Term Loans was 2.56% and the weighted average interest rate for the Revolving Credit Facility was 2.41%.

15

For more information, please refer to “Note 15. Long-term Debt and Credit Agreement” in our 2019 Annual Report on Form 10-K.

Note 11. Leases

The Company is party to operating leases for the majority of its manufacturing sites, offices, engineering and lab sites, stocking locations, warehouses, automobiles, and certain equipment. Certain of the Company’s real estate leases include variable rental payments which adjust periodically based on inflation, and certain automobile lease agreements include rental payments which fluctuate based on mileage. Generally, the Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company’s operating lease costs for the three and nine months ended September 26, 2020 and September 28, 2019 consisted of the following:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	5	$	4	$	13	$	12
Selling, general & administrative		13		10		33		27
Total operating lease costs	$	18	$	14	$	46	$	39

Total operating lease costs include variable lease costs of $5 million and $12 million, respectively, for the three and nine months ended September 26, 2020. For the three and nine months ended September 28, 2019, total operating lease costs included variable lease costs of $3 million and $8 million, respectively. Total operating lease costs also include offsetting sublease income which is immaterial for the three and nine months ended September 26, 2020 and September 28, 2019.

The Company recognized the following related to its operating leases:

	Financial Statement Line Item	At September 26, 2020		At December 31, 2019
Operating right-of-use assets	Other assets	$	134	$	137
Operating lease liabilities - current	Accrued liabilities	$	33	$	31
Operating lease liabilities - noncurrent	Other liabilities	$	109	$	111

Maturities of the Company’s operating lease liabilities were as follows:

	At September 26, 2020
2020	$	10
2021		39
2022		35
2023		28
2024		16
Thereafter		39
Total lease payments		167
Less: imputed interest		25
Present value of operating lease liabilities	$	142
Weighted-average remaining lease term (years)		5.44
Weighted-average incremental borrowing rate		6.00	%

16

Supplemental cash flow information related to the Company’s operating leases was as follows:

	Nine Months Ended
	September 26,		September 28,
	2020		2019
Operating cash outflows	$	22	$	28
Operating right-of-use assets obtained in exchange for operating lease liabilities	$	22	$	47

As of September 26, 2020, the Company has additional operating leases that have not yet commenced. Obligations under these leases are not material. Additionally, as a lessor, the Company leases all or a portion of certain owned properties. Rental income for the three and nine months ended September 26, 2020 and September 28, 2019 was not material.

Note 12. Stock-Based Compensation Plans

Restricted Stock Units (“RSUs”)

During the nine months ended September 26, 2020, as part of the Company’s annual long-term compensation under the 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates and the 2018 Stock Incentive Plan for Non-Employee Directors of Resideo Technologies, Inc. as may be amended from time to time (together, the “Stock Incentive Plan”), it granted 795,099 performance-based RSUs and 2,168,943 time-based RSUs to eligible employees. The weighted average grant date fair value per share for these shares was $9.18.

Stock Options

During the nine months ended September 26, 2020, as part of the Company’s annual long-term compensation under the Stock Incentive Plan, 1,083,665 stock options were granted to eligible employees at a weighted average exercise price per share of $9.17 and weighted average grant date fair value per share of $2.61.

Note 13. Commitments and Contingencies

Environmental Matters

The Company is subject to various federal, state, local and foreign government requirements relating to the protection of the environment and accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. Environmental-related expenses for sites owned and operated by Resideo are presented within Cost of goods sold for operating sites. For the three and nine months ended September 26, 2020 and September 28, 2019, environmental expenses related to these operating sites were not material. Liabilities for environmental costs were $22 million as of September 26, 2020 and December 31, 2019.

The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to our unaudited consolidated results of operations and operating cash flows in the periods recognized or paid.

17

Obligations Payable Under Indemnification Agreements

In connection with the Spin-Off, the Company entered into an indemnification and reimbursement agreement with Honeywell (the "Reimbursement Agreement") and a tax matters agreement (the "Tax Matters Agreement") (collectively, the "Indemnification Agreements") which are further described below.

Reimbursement Agreement

On October 29, 2018, in connection with the Spin-Off, the Company entered into the Reimbursement Agreement with Honeywell pursuant to which the Company has an obligation to make cash payments to Honeywell in amounts equal to 90% of payments for certain Honeywell environmental-liability payments, which include amounts billed (“payments”), less 90% of Honeywell’s net insurance receipts relating to such liabilities, and less 90% of the net proceeds received by Honeywell in connection with (i) affirmative claims relating to such liabilities, (ii) contributions by other parties relating to such liabilities and (iii) certain property sales (the “recoveries”). The amount payable by the Company in respect of such liabilities arising in respect of any given year is subject to a cap of $140 million (exclusive of any late payment fees up to 5% per annum). The scope of the Company’s current environmental remediation obligations subject to the Reimbursement Agreement relates to approximately 230 sites or groups of sites that are undergoing environmental remediation under U.S. federal or state law and agency oversight for contamination associated with Honeywell historical business operations. The ongoing environmental remediation is designed to address contaminants at upland and sediment sites, which include, among others, metals, organic compounds and polychlorinated biphenyls, through a variety of methods, which include, among others, excavation, capping, in-situ stabilization, groundwater treatment and dredging. In addition, the Company obligations subject to the Reimbursement Agreement include certain liabilities with respect to (i) hazardous exposure or toxic tort claims associated with the specified sites that arise after the Spin-Off, if any, (ii) currently unidentified releases of hazardous substances at or associated with the specified sites, (iii) other environmental claims associated with the specified sites and (iv) consequential damages.

Payments in respect of the liabilities arising in a given year will be made quarterly throughout such year on the basis of an estimate of the liabilities and recoveries provided by Honeywell. Following the end of any such year, Honeywell will provide the Company with a calculation of the amount of payments and the recoveries actually received.

Payment amounts under the Reimbursement Agreement will be deferred to the extent that a specified event of default has occurred and is continuing under certain indebtedness, including under the Company’s Credit Agreement, or the payment thereof causes the Company to not be compliant with certain financial covenants in certain indebtedness, including the Company’s Credit Agreement, on a pro forma basis, including the maximum total leverage ratio (ratio of consolidated debt to consolidated EBITDA, which excludes any amounts owed under the Reimbursement Agreement), and the minimum interest coverage ratio. A 5% late payment fee will accrue on all amounts that are not otherwise entitled to be deferred under the terms of the Reimbursement Agreement, without prejudice to any other rights that Honeywell may have for late payments.

The obligations under the Reimbursement Agreement will continue until the earlier of: (1) December 31, 2043; or (2) December 31 of the third consecutive year during which the annual reimbursement obligation (including in respect of deferred payment amounts) has been less than $25 million.

On April 21, 2020, the Company and Honeywell entered into an amendment to the Reimbursement Agreement (the "Reimbursement Agreement Amendment"). Pursuant to the Reimbursement Agreement Amendment, certain covenants in Exhibit G of the Reimbursement Agreement were modified to conform, if applicable, to the amended covenants included in the Credit Agreement Amendment. In addition, under the Reimbursement Agreement Amendment, the parties agreed to defer until no later than July 30, 2020 (which was further amended as described below) the $35 million quarterly payment otherwise payable to Honeywell on April 30, 2020. The Reimbursement Agreement Amendment expressly reserves all rights of the parties thereto and their respective affiliates in respect of the Reimbursement Agreement and each other contract or agreement between such parties or their affiliates (the “Other Agreements”), and provides that the execution of the amendment does not constitute a waiver of any claims, rights, remedies, defenses, arguments, interpretations or obligations of such parties or their affiliates under or related to the Reimbursement Agreement or any Other Agreement.

18

On July 28, 2020, the Company and Honeywell entered into the Second Reimbursement Agreement Amendment. Pursuant to the Second Reimbursement Agreement Amendment, the parties agreed to further defer until no later than October 30, 2020 the $35 million quarterly payment that was originally due thirty days following the start of the second quarter of 2020 and was previously deferred until no later than July 30, 2020 pursuant to the Reimbursement Agreement Amendment. The deferred payment was made on October 30, 2020.

The following table summarizes information concerning our Reimbursement Agreement liabilities:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning balance	$	585		$	616
Accruals for indemnification liabilities deemed probable and reasonably estimable		107			138
Reduction (1)		-			(81	)
Indemnification payment		(70	)		(105	)
Ending balance (2)	$	622		$	568

(1) Reduction in indemnification liabilities relates to a provision in the Reimbursement Agreement that reduces the obligation due to Honeywell for any proceeds received by Honeywell from a property sale of a site under the agreement.

(2) Reimbursement Agreement liabilities deemed probable and reasonably estimable, however, it is possible the Company could pay $140 million per year (exclusive of any late payment fees up to 5% per annum) until the earlier of (1) December 31, 2043; or (2) December 31 of the third consecutive year during which the annual reimbursement obligation (including in respect of deferred payment amounts) has been less than $25 million.

For the three and nine months ended September 26, 2020, net expenses related to the Reimbursement Agreement were $38 million and $107 million, respectively, and for the three and nine months ended September 28, 2019, expenses related to the Reimbursement Agreement were $35 million and $57 million, respectively, and are recorded in Other expense, net. Reimbursement Agreement liabilities are included in the following balance sheet accounts:

	September 26, 2020		December 31, 2019
Accrued liabilities	$	175	$	140
Obligations payable under Indemnification Agreements		447		445
	$	622	$	585

The Company does not currently possess sufficient information to reasonably estimate the amounts of indemnification liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to our unaudited consolidated results of operations and operating cash flows in the periods recognized or paid.

Tax Matters Agreement

In connection with the Spin-Off, the Company entered into the Tax Matters Agreement with Honeywell pursuant to which it is responsible and will indemnify Honeywell for all taxes, including income taxes, sales taxes, VAT and payroll taxes, relating to the business for all periods, including periods prior to the consummation of the Spin-Off. As of September 26, 2020 and December 31, 2019, the Company had an indemnity outstanding to Honeywell for future tax payments of $139 million and $149 million, respectively, which is included in Obligations payable under Indemnification Agreements.

19

Trademark Agreement

In connection with the Spin-Off, the Company and Honeywell entered into a 40-year Trademark License Agreement (the “Trademark Agreement”) that authorizes the Company’s use of certain licensed trademarks in the operation of Resideo’s business for the advertising, sale and distribution of certain licensed products. In exchange, the Company pays a royalty fee of 1.5% on net revenue to Honeywell related to such licensed products which is recorded in Selling, general and administrative expense on the unaudited Consolidated Interim Statements of Operations. For the three and nine months ended September 26, 2020, royalty fees were $7 million and $18 million, respectively. For the three and nine months ended September 28, 2019, royalty fees were $6 million and $20 million, respectively.

Other Matters

The Company is subject to lawsuits, investigations and disputes arising out of the conduct of its business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee matters, intellectual property, and environmental, health and safety matters. The Company recognizes a liability for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. No such matters are material to the Company's unaudited financial statements.

The Company, the Company’s former CEO Michael Nefkens, the Company’s former CFO Joseph Ragan, and the Company’s former CIO Niccolo de Masi are named defendants of a class action securities suit in the District court for the District of Minnesota styled In re Resideo Technologies, Inc. Securities Litigation, 19-cv-02863 (the “Securities Litigation”). The Securities Litigation is a class action securities suit with the class defined as all persons or entities who purchased or otherwise acquired common stock of Resideo during the class period of October 29, 2018 to November 6, 2019. The complaint asserts claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, broadly alleging, among other things, that the defendants (or some of them) made false and misleading statements regarding, among other things, Resideo’s business, performance, the efficiency of its supply chain, operational and administrative issues resulting from the spin-off from Honeywell, certain business initiatives, and financial guidance in 2019. The defendants filed a motion to dismiss the complaint on July 10, 2020. We expect the motion to dismiss to be fully briefed in November 2020. A hearing on the motion to dismiss is currently scheduled for December 1, 2020. See “Note 19. Commitments and Contingencies” of Notes to Consolidated and Combined Financial Statements in our 2019 Annual Report on Form 10-K for further discussion. The Company intends to vigorously defend against the allegations in the Securities Litigation, but there can be no assurance that the defense will be successful.

20

On July 7, 2020, Jawad A. Ayaz as Trustee of the Shiv Venkatasetty 2016 Trust (“Derivative Plaintiff”) filed a shareholder derivative complaint (the “Derivative Complaint”) against certain current or former directors and officers of the Company (“Derivative Defendants”) in the District Court for the District of Delaware, captioned Ayaz v. Nefkens, 20-cv-00915. Derivative Plaintiff alleges generally that Derivative Defendants breached fiduciary duties owed to the Company by allegedly causing or allowing the Company to make materially false and misleading statements to the public regarding the Company’s business operations and financial prospects. Derivative Plaintiff also alleges that the Company’s 2019 proxy statement was materially false and misleading, in violation of Section 14(a) of the Securities Exchange Act of 1934, and asserts claims of corporate waste and unjust enrichment, among other allegations, and relies on a similar set of facts as alleged in the Securities Litigation. The Derivative Complaint seeks declaratory relief and unspecified money damages on behalf of the Company. On July 28, 2020, certain of the Derivative Defendants filed a stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation. An additional shareholder derivative complaint was filed on August 12, 2020, by Plaintiff Daniel Sanclemente (the “Sanclemente Action”) on behalf of the Company in the District Court for the District of Delaware, captioned Sanclemente v. Nefkens, 20-cv-1062, alleging substantially the same facts and making substantially the same claims against the same defendants as in the Derivative Complaint. The District Court has consolidated the Derivative Complaint and the Sanclemente Action. The consolidated action is styled In re Resideo Technologies, Inc. Derivative Litigation, 20-cv-00915 (the “Derivative Action”), and lead counsel has been appointed. Additionally, the pending stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation was granted and is applicable to the consolidated action. On August 28, 2020, Riviera Beach Police Pension Fund (“Riviera Beach”) filed a motion to intervene in the Derivative Action, noticing its intent to file a complaint at some point in the future against some or all of the Derivative Defendants. As of September 18, 2020, Riviera Beach and the existing plaintiffs reached an agreement regarding the leadership structure of the Derivative Action in the event that Riviera Beach files its own complaint in the future. The Company intends to defend this action vigorously, but there can be no assurance that the defense will be successful.

Warranties and Guarantees

In the normal course of business, the Company issues product warranties and product performance guarantees. It accrues for the estimated cost of product warranties and product performance guarantees based on contract terms and historical experience at the time of sale. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. Product warranties and product performance guarantees are included in Accrued liabilities.

The following table summarizes information concerning recorded obligations for product warranties and product performance guarantees:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning of period	$	25		$	26
Accruals for warranties/guarantees issued during the year		13			10
Adjustment of pre-existing warranties/guarantees		-			(1	)
Settlement of warranty/guarantee claims		(12	)		(12	)
End of period	$	26		$	23

21

Note 14. Pension

The Company sponsors multiple funded and unfunded U.S. and non-U.S. defined benefit pension plans. Pension benefits for many of its U.S. employees are provided through non-contributory, qualified and non-qualified defined benefit plans. It also sponsors defined benefit pension plans which cover non-U.S. employees who are not U.S. citizens, in certain jurisdictions, principally Germany, Austria, Belgium, France, India, Switzerland, and the Netherlands. The pension obligations as of September 26, 2020 and December 31, 2019 were $135 million and $124 million, respectively, and are included in Other liabilities in the unaudited Consolidated Interim Balance Sheets. Net periodic benefit cost recognized in Comprehensive income (loss) for the three and nine months ended September 26, 2020 is $2 million and $6 million, respectively. Net periodic benefit cost recognized in Comprehensive income (loss) for the three and nine months ended September 28, 2019 was $2 million and $5 million, respectively.

The components of net periodic benefit costs other than the service cost are included in Other expense, net in the unaudited Consolidated Interim Statements of Operations for the three and nine months ended September 26, 2020 and September 28, 2019.

Note 15. Segment Financial Data

The Company globally manages its business operations through two reportable operating segments, Products & Solutions and ADI Global Distribution:

Products & Solutions—The Products & Solutions business is a leading global provider of products, software solutions and technologies that help homeowners stay connected and in control of their comfort, security and energy use.

ADI Global Distribution—The ADI Global Distribution business is a leading global distributor of low-voltage electronic and security products.

Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance.

The Company’s Chief Operating Decision Maker evaluates segment performance based on Segment Adjusted EBITDA. Segment Adjusted EBITDA is defined as segment net income (loss) before income taxes, net interest expense (income), depreciation and amortization plus environmental expense, Reimbursement Agreement expense, stock compensation expense, restructuring charges and other adjustments.

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Revenue
Total Products & Solutions revenue	$	674	$	595	$	1,715	$	1,828
Less: Intersegment revenue		102		83		270		228
External Products & Solutions revenue		572		512		1,445		1,600
External ADI Global Distribution revenue		790		714		2,125		2,084
Total revenue	$	1,362	$	1,226	$	3,570	$	3,684

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Segment Adjusted EBITDA
Products & Solutions	$	136	$	66	$	224	$	222
ADI Global Distribution		52		48		126		141
Segment Adjusted EBITDA	$	188	$	114	$	350	$	363

22

The table below provides a reconciliation of net income (loss) to Segment Adjusted EBITDA:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Net interest expense (1)		14		16		48			49
Tax expense		7		-		26			36
Depreciation and amortization		22		19		64			55
Reimbursement Agreement expense (2)		38		35		107			57
Stock compensation expense (3)		7		8		21			22
Restructuring charges		7		9		27			34
Other (4)		18		19		79			65
Segment Adjusted EBITDA	$	188	$	114	$	350		$	363

(1) For the three and nine months ended September 26, 2020 net interest expense consists of interest expense of $14 million and $49 million net of interest income of $0 million and $1 million, respectively. For the three and nine months ended September 28, 2019 net interest expense consists of interest expense of $16 million and $51 million net of interest income of $0 million and $2 million, respectively.

(2) Represents recorded net expenses related to the Reimbursement Agreement. 

(3) Stock compensation expense adjustment includes only non-cash expenses.

(4) For the three and nine months ended September 26, 2020, Other represents $9 million and $36 million of items related to the Spin-Off, $12 million and $41 million of consulting and other fees related to transformation programs, ($3) million and $1 million of non-operating (income) expense adjustment which excludes net interest (income), and $0 million and $1 million of acquisition-related expenses, respectively. For the three and nine months ended September 28, 2019, Other represents $19 million and $53 million of cost directly related to the Spin-Off, $0 million and $13 million related to developments on legal claims that arose prior to Spin-Off, and $0 million and ($1) million in non-operating (income) expense adjustment which excludes net interest (income), respectively.

The Company’s CODM does not use segment assets information to allocate resources or to assess performance of the segments and therefore, total segment assets have not been disclosed.

23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

(Dollars in millions, except per share amounts)

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to help you understand the results of operations and financial condition of Resideo Technologies, Inc. and its consolidated subsidiaries (“Resideo” or “the Company”, “we”, “us” or “our”) for the three and nine months ended September 26, 2020 and should be read in conjunction with the unaudited Consolidated Interim Financial Statements and the notes thereto contained elsewhere in this Form 10-Q. The financial information as of September 26, 2020 should be read in conjunction with the consolidated and combined financial statements for the year ended December 31, 2019 contained in our 2019 Annual Report on Form 10-K (the “2019 Annual Report on Form 10-K”).

Overview and Business Trends

We are a leading global provider of products, software solutions and technologies that help homeowners stay connected and in control of their comfort, security and energy use. We are a leader in the home heating, ventilation and air conditioning controls and security markets. We manage our business operations through two segments, Products & Solutions and ADI Global Distribution. Our Products & Solutions segment consist of solutions in Comfort, Residential Thermal Solutions (“RTS”) and Security categories and includes temperature and humidity control, thermal, water and air solutions and remote patient monitoring software solutions as well as security panels, sensors, peripherals, wire and cable, communications devices, video cameras, awareness solutions, cloud infrastructure, installation and maintenance tools and related software. Our ADI Global Distribution business is the leading wholesale distributor of low-voltage electronic and security products which include intrusion and smart home, fire, video surveillance, access control, power, audio and video, ProAV, networking, communications, wire and cable, enterprise connectivity and structured wiring. The Products & Solutions segment, consistent with our industry, has a higher gross and operating margin profile in comparison to the ADI Global Distribution segment.

Our Chief Operating Decision Maker evaluates segment performance based on Segment Adjusted EBITDA. Segment Adjusted EBITDA is defined as segment net income (loss) before income taxes, net interest expense (income), depreciation and amortization plus or minus environmental expense, expenses related to the indemnification and reimbursement agreement with Honeywell (the “Reimbursement Agreement”), stock compensation expense, restructuring charges, other expense, net and other costs not directly related to future ongoing business of the segments, such as costs related to becoming an independent publicly traded company (“the Spin-Off”) on October 29, 2018 and costs related to restructuring programs.

Our financial performance is influenced by several macro factors such as repair and remodeling activity, residential and non-residential construction, employment rates, and overall macro environment. The global outbreak of a novel coronavirus disease (“COVID-19”) created economic disruption. Starting at the end of the first quarter and throughout the second quarter, we experienced constrained supply and slowed customer demand that adversely impacted business, results of operations and overall financial performance. Although there remains uncertainty as to the continuing implications of COVID-19, during third quarter customer demand has improved and cost actions taken during the first half of the year contributed to the improvements in the Company’s results of operations and overall financial performance.

Recent Developments

COVID-19 Pandemic

The World Health Organization (“WHO”) declared COVID-19 a pandemic in March 2020. The broader implications of COVID-19 on our results of operations and overall financial performance remain uncertain. Starting at the end of the first quarter and throughout the second quarter, we experienced constrained supply and slowed customer demand that adversely impacted business, results of operations and overall financial performance in future periods. See “Item 1A. Risk Factors” of this Form 10-Q for further discussion of the possible impact of the COVID-19 pandemic on our business. As there remains uncertainty around the impacts of the COVID-19 pandemic, we address and evaluate the impacts regularly.

24

U.S. and international government responses to the COVID-19 outbreak have included “shelter in place,” “stay at home” and similar types of orders. In the United States, Canada and certain other countries globally, these orders exempt certain products and services needed to maintain continuity of operations of critical infrastructure sectors as determined by the federal government. Although certain of the Company’s operations are currently considered essential and exempt in the United States, Canada and certain other countries globally, there remain certain jurisdictions where there have been and may continue to be restrictions on manufacturing or operations or other government lockdown mandates or recommendations, under which we have temporarily closed certain manufacturing and sales facilities, and restricted operations in others, including manufacturing in Mexico and restricted operations in certain ADI sales branches, although certain of these facilities have since reopened or remained opened with restricted sales activities. If any of the applicable exemptions are curtailed or revoked in the future, that could adversely impact our business, operating results and financial condition. Furthermore, to the extent these exemptions do not extend to our key suppliers and customers, this could also adversely impact our business, operating results and financial condition. We have also implemented work-from-home policies for a significant percentage of our employees, which could negatively impact productivity, disrupt conduct of our business in the ordinary course and delay our production timelines. Due to the significant remote workforce populations, we may also face informational technology infrastructure and connectivity issues from the vendors that we rely on for certain information technologies to administer, store and support the Company’s multiple business activities. Finally, we are incurring increased costs associated with cleaning and other employee safety measures.

Our visibility toward future performance is more limited than is typical due to the uncertainty surrounding the duration and ultimate impact of COVID-19 and the mitigation measures that are implemented by governmental authorities. We also expect business conditions to remain challenging. In response to these challenges, we will continue to focus on those factors that we can control: closely managing and controlling our expenses; aligning our production schedules with demand in a proactive manner as there are changes in market conditions to minimize our cash operating costs; and pursuing further improvements in the productivity and effectiveness of our manufacturing, selling and administrative activities.

2020 Acquisition

On February 10, 2020, we completed the acquisition of privately held Herman ProAV (“Herman"), a leading provider and distributer of professional audio-visual products, procurement services and labor resources to systems integrators in the commercial audio-visual industry. This acquisition was integrated into and builds upon ADI Global Distribution’s product portfolio and expands its presence in the pro-AV market.

Third Quarter Highlights

Net revenue increased $136 million in the third quarter of 2020 compared to the same quarter of 2019, with increased sales growth in both Products & Solutions and ADI Global Distribution. Gross profit as a percent of net revenues increased to 27% in the third quarter of 2020 from 25% in the third quarter of 2019. The primary drivers to the increase in gross profit percentage were a 100 bps favorable impact as a result of higher revenue volumes in Products & Solutions and ADI Global Distribution, 100 bps favorable impact from transformation programs cost savings, and a 100 bps favorable impact from sourcing productivity. These impacts were partially offset by a 100 bps unfavorable impact from sales mix changes and increased factory costs related to COVID-19 employee safety measures. Third quarter net income was $75 million for the three months ended September 26, 2020 compared to net income of $8 million for the three months ended September 28, 2019.

Selling, general, and administrative expenses decreased by $11 million in the recent quarter compared to the third quarter of 2019. The decrease was driven by transformation programs cost savings, decrease in Spin-Off related expense, cost reduction actions including COVID-19 related cost management efforts, and other cost reductions totaling $47 million. These decreases were partially offset by restructuring related costs, labor and other cost inflation, foreign currency translation, impact of acquisitions, and commercial investments totaling $36 million.

We ended the third quarter with $260 million in cash and cash equivalents. Net cash provided by operating activities was $92 million for the nine months ended September 26, 2020. At September 26, 2020, accounts receivable were $884 million, inventories were $618 million and $150 million was drawn under our revolving credit facility.    

25

Basis of Presentation

Our financial statements are presented on a consolidated basis (collectively, the “Interim Financial Statements”). The Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Reclassification

On January 1, 2020, we changed the classification of research and development expenses in the Consolidated Interim Statements of Operations from Cost of goods sold to Selling, general and administrative expenses, such that research and development expenses are excluded from the calculation of Gross profit. The impact on the September 28, 2019 Consolidated Interim Statement of Operations is a reduction of Cost of goods sold, an increase in Gross profit and an increase in Selling, general and administrative expenses for the three and nine months ended September 28, 2019 of $20 million and $66 million, respectively. This reclassification had no effect on the previously reported Net income (loss) or the Company’s Consolidated Interim Statements of Comprehensive Income (Loss), Consolidated Interim Statements of Cash Flows, or Consolidated Interim Balance sheets.

Components of Operating Results

The key elements of our operating results include:

Net Revenue

We globally manage our business operations through two reportable segments, Products & Solutions and ADI Global Distribution:

Products & Solutions. We generate the majority of our Product & Solutions net revenue primarily from residential end-markets. Our Products & Solutions segment includes traditional products, as well as connected products, which we define as any device with the capability to be monitored or controlled from a remote location by an end-user or service provider. Our products are sold through a network of distributors (e.g. HVAC, plumbing, Security, Electrical), OEMs, and service providers such as HVAC contractors, security dealers and plumbers including our ADI Global Distribution business. We also sell some products via retail and online channels.

ADI Global Distribution. We generate revenue through the distribution of low-voltage electronic and security products that are delivered through a comprehensive network of professional contractors, distributors and OEMs, as well as major retailers and online merchants. In addition to our own Security products, ADI Global Distribution distributes products from industry-leading manufacturers and ADI Global Distribution also carries a line of private label products. We sell these products to contractors that service non-residential and residential end-users. 15% of ADI Global Distribution’s net revenue is supplied by our Products & Solutions segment. Management estimates that in 2019 and 2020 approximately two-thirds of ADI Global Distribution’s net revenue was attributed to non-residential end markets and one-third to residential end markets.

Cost of Goods Sold

Products & Solutions: Cost of goods sold includes costs associated with raw materials, assembly, shipping and handling of those products; costs of personnel-related expenses, including pension benefits, and equipment associated with manufacturing support, logistics and quality assurance; and costs of certain intangible assets.

ADI Global Distribution: Cost of goods sold consists primarily of inventory-related costs and includes labor and personnel-related expenses.

26

Selling, General, and Administrative Expense

Selling, general and administrative expense includes trademark royalty expenses, sales incentives and commissions, professional fees, legal fees, promotional and advertising expenses, personnel-related expenses, including stock compensation expense and pension benefits, and research and development expenses.

Other Expense, Net

Other expense, net consists primarily of Reimbursement Agreement expenses (gains) for certain environmental claims related to approximately 230 sites or groups of sites that are undergoing environmental remediation under U.S. federal or state law and agency oversight for contamination associated with Honeywell historical business operations. For further information see the “Reimbursement Agreement” section of this Management’s Discussion and Analysis of Financial Condition and Results of Operations and “Note 13. Commitments and Contingencies” of Notes to Interim Financial Statements of this Form 10-Q. Other expense, net also includes foreign exchange gains and losses.

Interest Expense

Interest expense consists of interest on our short and long-term obligations, including our senior notes, term credit facility, and revolving credit facility. Interest expense on our obligations includes contractual interest, amortization of the debt discount and amortization of deferred financing costs.

Tax Expense

Provision for income taxes includes both domestic and foreign income taxes at the applicable statutory tax rates, adjusted for U.S. taxation of foreign earnings and other non-deductible expenses.

Results of Operations

The following table sets forth our selected unaudited consolidated interim statements of operations for the periods presented:

Unaudited Consolidated Interim Statements of Operations

(Dollars in millions except share and per share data)

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net revenue	$	1,362	$	1,226	$	3,570		$	3,684
Cost of goods sold		992		917		2,680			2,720
Gross profit		370		309		890			964
Selling, general and administrative expenses		239		250		731			778
Operating profit		131		59		159			186
Other expense, net		35		35		106			54
Interest expense		14		16		49			51
Income before taxes		82		8		4			81
Tax expense		7		-		26			36
Net income (loss)	$	75	$	8	$	(22	)	$	45
Weighted Average Number of Common Shares Outstanding (in thousands)
Basic		123,421		122,770		123,194			122,681
Diluted		125,235		123,244		123,194			123,404
Earnings (Loss) Per Share
Basic	$	0.61	$	0.07	$	(0.18	)	$	0.37
Diluted	$	0.60	$	0.06	$	(0.18	)	$	0.36

27

Results of Operations for the Three and Nine Months Ended September 26, 2020 and September 28, 2019

Net Revenue

	Three Months Ended					Nine Months Ended
	September 26,			September 28,		September 26,			September 28,
	2020			2019		2020			2019
Net revenue	$	1,362		$	1,226	$	3,570		$	3,684
% change compared with prior period		11	%				(3	)%

The change in net revenue compared to prior year period is attributable to the following:

	Three Months Ended September 26, 2020	Nine Months Ended September 26, 2020
Volume	7 %	(5)%
Price	1 %	1 %
Acquisitions	2 %	1 %
Foreign currency translation	1 %	0 %
% change compared with prior period	11 %	(3)%

A discussion of net revenue by segment can be found in the “Review of Business Segments” section of this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Cost of Goods Sold

	Three Months Ended						Nine Months Ended
	September 26,			September 28,			September 26,				September 28,
	2020			2019			2020				2019
Cost of goods sold	$	992		$	917		$	2,680			$	2,720
% change compared with prior period		8	%					(1	)	%
Gross profit percentage		27	%		25	%		25		%		26	%

Three months ended

Cost of goods sold for the three months ended September 26, 2020 was $992 million, an increase of $75 million, or 8%, from $917 million for the three months ended September 28, 2019.

This increase in cost of goods sold was driven by higher revenue volumes in Products & Solutions and ADI Global Distribution, impact of expenses related to revenue that are attributable to the operations of Herman, unfavorable changes in sales mix, foreign currency translation, increased factory costs related to COVID-19 employee safety measures, and material and labor inflation totaling $97 million. The increased costs were partially offset by sourcing productivity and transformation programs cost savings totaling $22 million.

The primary drivers to the increase in gross profit percentage were a 100 bps favorable impact as a result of higher revenue volumes in Products & Solutions and ADI Global Distribution, 100 bps favorable impact from transformation programs cost savings, and a 100 bps favorable impact from sourcing productivity. These impacts were partially offset by a 100 bps unfavorable impact from sales mix changes and increased factory costs related to COVID-19 employee safety measures.

Nine months ended

Cost of goods sold for the nine months ended September 26, 2020 was $2,680 million, a decrease of $40 million, or 1%, from $2,720 million for the nine months ended September 28, 2019.

28

This decrease in cost of goods sold was driven by lower revenue volumes in primarily Products & Solutions, sourcing productivity, transformation programs cost savings, foreign currency translation, and reduced Spin-Off related costs totaling $163 million. The decreased costs were partially offset by the impact of expenses related to revenue that are attributable to the operations of Herman, changes in sales mix, increased factory costs related to COVID-19 employee safety measures, material and labor inflation, restructuring related costs, and other miscellaneous costs of goods sold totaling $123 million.

The primary drivers to the decrease in gross profit percentage were a 100 bps unfavorable impact as a result of lower revenue volumes primarily in Products & Solutions, and a 100 bps unfavorable impact from sales mix changes. These impacts were partially offset by 100 bps favorable impact from transformation programs cost savings.

Selling, General and Administrative Expense

	Three Months Ended						Nine Months Ended
	September 26,			September 28,			September 26,			September 28,
	2020			2019			2020			2019
Selling, general and administrative expense	$	239		$	250		$	731		$	778
% of revenue		18	%		20	%		20	%		21	%

Three months ended

Selling, general and administrative expense for the three months ended September 26, 2020 was $239 million, a decrease of $11 million, from $250 million for the three months ended September 28, 2019. The decrease was driven by transformation programs cost savings, decrease in Spin-Off related expense, cost reduction actions including COVID-19 related cost management efforts, and other cost reductions totaling $47 million. These decreases were partially offset by restructuring related costs, labor and other cost inflation, foreign currency translation, impact of acquisitions, and commercial investments totaling $36 million.

Nine months ended

Selling, general and administrative expense for the nine months ended September 26, 2020 was $731 million, a decrease of $47 million, from $778 million for the nine months ended September 28, 2019. The decrease was driven by transformation programs cost savings, cost reduction actions including COVID-19 related cost management efforts, decrease in Spin-Off related expense, and other cost reductions totaling $135 million. These decreases were partially offset by restructuring related costs, labor and other cost inflation, impact of acquisitions, and commercial investments totaling $88 million.

Other Expense, Net

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Other expense, net	$	35	$	35	$	106	$	54

Three months ended

Other expense, net for the three months ended September 26, 2020 and the three months ended September 28, 2019 was expense of $35 million. Other expense, net increased $3 million from the Reimbursement Agreement offset by $2 million in favorable foreign exchange impact and a $1 million decrease in other non-operating expense.

29

Nine months ended

Other expense, net for the nine months ended September 26, 2020, was expense of $106 million, an increase of $52 million from $54 million for the nine months ended September 28, 2019. In the nine months ended September 26, 2020, we recognized $107 million in expense from the Reimbursement Agreement compared to $57 million for the nine months ended September 28, 2019. The major driver for the increase over the prior period is related to a gain recorded in the first quarter of 2019 related to proceeds received from a property sale of a site under the agreement. Total increases also include $4 million from unfavorable foreign exchange impact, partially offset by a $2 million decrease in other non-operating expenses.

Tax Expense

	Three Months Ended						Nine Months Ended
	September 26,			September 28,			September 26,			September 28,
	2020			2019			2020			2019
Tax expense	$	7		$	-		$	26		$	36
Effective tax rate		8	%		0	%		729	%		44	%

The Company recorded a tax expense of $7  million and $26 million for the three and nine months ended September 26, 2020, respectively.

For interim periods, income tax is equal to the total of (1) year-to-date pretax income multiplied by our forecasted effective tax rate plus (2) tax expense items specific to the period. In situations where we expect to report losses for which we do not expect to receive tax benefits, we are required to apply separate forecasted effective tax rates to those jurisdictions rather than including them in the consolidated forecasted effective tax rate.

Three months ended

For the three months ended September 26, 2020, the net tax expense of $7 million was driven by interim period tax expense of $7 million based on year-to-date actual amounts. Tax expense specific to the period was $0. In addition to items specific to the period, our income tax rate is impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

Nine months ended

For the nine months ended September 26, 2020, the net tax expense of $26 million was driven by the year-to-date tax expense of $11 million based on year-to-date actual amounts, and tax expense specific to the period of approximately $15 million, consisting primarily of $15 million for valuation allowances in foreign jurisdictions, $2 million related to the estimated tax impact of the CARES Act on prior years, and share-based excess cost of $1 million, partially offset by a $3 million tax benefit for changes in estimates related to prior years. In addition to items specific to the period our income tax rate/expense are impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

Review of Business Segments

Products & Solutions

	Three Months Ended							Nine Months Ended
	September 26,		September 28,					September 26,		September 28,
	2020		2019		% Change			2020		2019		% Change
Total revenue	$	674	$	595				$	1,715	$	1,828
Less: Intersegment revenue		102		83					270		228
External revenue	$	572	$	512		12	%	$	1,445	$	1,600		(10	)%
Segment Adjusted EBITDA	$	136	$	66		106	%	$	224	$	222		1	%

30

Three months ended

Products & Solutions revenue increased 12%, with increased revenue volumes across all businesses. Segment Adjusted EBITDA increased from $66 million to $136 million, or 106%. Segment Adjusted EBITDA was positively impacted by higher revenue, cost savings from transformation programs, COVID-19 related cost management actions, reduced inventory reserve costs, and other cost reduction efforts including product cost reduction programs totaling $95 million. These impacts were partially offset by unfavorable changes in sales mix, increased factory costs related to COVID-19 employee safety measures, investments to support new product launches and labor and material inflation totaling $25 million. 

Nine months ended

Products & Solutions revenue declined 10%, yet Segment Adjusted EBITDA increased from $222 million to $224 million, or 1%. Despite sales declines largely driven by second quarter COVID-19 impacts, Segment Adjusted EBITDA was positively impacted by cost savings from transformation programs, COVID-19 related cost management actions, reduced inventory reserve costs, and other cost reduction efforts including product cost reduction programs totaling $159 million. These cost reductions offset lower revenue volumes, unfavorable sales mix, increased factory operating costs attributable to COVID-19 employee safety measures, investments to support new product launches, and labor and material inflation totaling $157 million.

ADI Global Distribution

	Three Months Ended							Nine Months Ended
	September 26,		September 28,					September 26,		September 28,
	2020		2019		% Change			2020		2019		% Change
External revenue	$	790	$	714		11	%	$	2,125	$	2,084		2	%
Segment Adjusted EBITDA	$	52	$	48		8	%	$	126	$	141		(11	)%

Three months ended

ADI Global Distribution revenue increased 11%, highlighted by strong growth in U.S. and Canada, as well as EMEA. Segment Adjusted EBITDA of $52 million was up $4 million or 8%. Segment Adjusted EBITDA was favorably impacted primarily by higher revenue, cost reduction actions including COVID-19 related cost management efforts and other expense productivity totaling $15 million. These positive impacts were partially offset by unfavorable sales mix, as well as commercial investments and other cost inflation totaling $11 million.

Nine months ended

ADI Global Distribution revenue increased 2%, while Segment Adjusted EBITDA of $126 million was down $15 million or 11%. Segment Adjusted EBITDA was negatively impacted primarily by COVID-19 related slowdowns in the second quarter, unfavorable sales mix, commercial investments, and other cost inflation totaling $41 million. Negative impacts were partially offset by cost reduction actions including COVID-19 related cost management actions, transformation programs and other expense productivity totaling $26 million.

31

Restructuring Charges

We have an ongoing financial and operational review which is focused on product cost and gross margin improvement, and general and administrative expenses simplification. We have retained industry-recognized experts in supply chain optimization and organizational excellence to assist in the review. Certain restructuring actions have been and are continuing to be implemented under this program as well as previous programs. These restructuring actions are expected to generate incremental pre-tax savings of $40 million to $45 million, net of costs of implementation which includes severance and consulting fees, in 2020 compared with 2019 principally from planned workforce reductions. Cash spending related to our restructuring actions was $23 million for the nine months ended September 26, 2020 and was funded through operating cash flows.

Net restructuring and related expenses were $7 million and $27 million for the three and nine months ended September 26, 2020, respectively, primarily related to severance. Net restructuring and related expenses were $9 million and $34 million for the three and nine months ended September 28, 2019, respectively, and primarily related to severance. For further discussion of restructuring activities, refer to Note 6. Restructuring and Other Charges of Notes to Consolidated Interim Financial Statements of this Form 10-Q.

Capital Resources and Liquidity

Our liquidity is primarily dependent on our ability to continue to generate cash flows from operations, supplemented by external sources of capital as needed.

• Cash flows provided by operating activities was $92 million for the nine months ended September 26, 2020. Cash flows used for operating activities was $70 million for the nine months ended September 28, 2019.

• As of September 26, 2020, total cash and cash equivalents were $260 million.

• At September 26, 2020, there were $150 million of borrowings and no letters of credit issued under our $350 million revolving credit facility.

Our future capital requirements will depend on many factors, including the impact of the COVID-19 pandemic, the rate of sales growth, market acceptance of our products, the timing and extent of research and development projects, potential acquisitions of companies or technologies and the expansion of our sales and marketing activities. We believe our existing cash, cash equivalents, and credit under our credit facilities are sufficient to meet our capital requirements through at least the next 12 months.

Reimbursement Agreement

In connection with the Spin-Off, we entered into the Reimbursement Agreement, pursuant to which we have an obligation to make cash payments to Honeywell in amounts equal to 90% of payments for certain Honeywell environmental-liability payments, which include amounts billed, less 90% of Honeywell’s net insurance receipts relating to such liabilities, and less 90% of the net proceeds received by Honeywell in connection with (i) affirmative claims relating to such liabilities, (ii) contributions by other parties relating to such liabilities and (iii) certain property sales. The amount payable by us in respect of such liabilities arising in any given year is subject to a cap of $140 million (exclusive of any late payment fees up to 5% per annum). During 2020, we entered into two amendments with Honeywell. See “Note 13. Commitments and Contingencies” of Notes to Consolidated Interim Financial Statements of this Form 10-Q for a discussion of the Reimbursement Agreement amendments. The amount paid during the nine months ended September 26, 2020 was $70 million. See “Note 19. Commitments and Contingencies” of Notes to Consolidated and Combined Financial Statements in our 2019 Annual Report on Form 10-K for further discussion.

32

Cash Flow Summary for the Nine Months Ended September 26, 2020 and September 28, 2019

Our cash flows from operating, investing and financing activities for the nine months ended September 26, 2020 and September 28, 2019, as reflected in the unaudited Interim Financial Statements are summarized as follows:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Cash provided by (used for):
Operating activities	$	92		$	(70	)
Investing activities		(85	)		(83	)
Financing activities		135			22
Effect of exchange rate changes on cash and cash equivalents		(4	)		(2	)
Net increase (decrease) in cash and cash equivalents	$	138		$	(133	)

Cash provided by operating activities for the nine months ended September 26, 2020 increased by $162 million, primarily due to the impacts from the slow-down of our business related to the COVID-19 pandemic. We saw a decrease in sales and related purchases starting at the end of the first quarter with the most significant decreases in the first two months of the second quarter. Due to the timing of collections and payments, our working capital decreased significantly as we were collecting/paying on higher balances. In addition, we deferred a significant amount of payments, including the Reimbursement Agreement payment of $35 million, which resulted in preservation of cash. We expect to have a decrease in cash during the fourth quarter of the 2020.

Cash used for investing activities increased by $2 million, primarily due to $18 million of additional cash paid for acquisitions, partially offset by a decrease of $16 million of cash paid for capital expenditures.

Net cash provided by financing activities increased by $113 million. The increase in cash provided by financing activities was primarily due to an increase of $90 million of borrowings under our $350 million revolving credit facility to increase our cash position in light of the economic uncertainty surrounding the COVID-19 pandemic, partially offset by decreases of $22 million of non-operating obligations paid to Honeywell and $1 million of tax payments related to stock vestings.

Capital Expenditures

We believe our capital spending has been sufficient to support the requirements of the business. We expect to continue investing to expand and modernize our existing facilities and to create capacity for new product development.

Off-Balance Sheet Arrangements

We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, net revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

33

Critical Accounting Policies

The preparation of our unaudited Interim Financial Statements in accordance with U.S. GAAP is based on the selection and application of accounting policies that require us to make significant estimates and assumptions about the effects of matters that are inherently uncertain. We consider the accounting policies discussed in our 2019 Annual Report on Form 10-K to be critical to the understanding of our unaudited Interim Financial Statements included in this Form 10-Q. There have been no changes in our critical accounting policies as compared to what was disclosed in the 2019 Annual Report on Form 10-K. Actual results could differ from our estimates and assumptions, and any such differences could be material to our unaudited Interim Financial Statements. As there remains uncertainty around the impacts of the COVID-19 pandemic, we intend to address and evaluate the impacts frequently. See “Note 2. Summary of Significant Accounting Policies” of Notes to Consolidated Interim Financial Statements of this Form 10-Q for a discussion of the accounting policies most likely affected by the COVID-19 pandemic.

Other Matters

Litigation, Environmental Matters and Reimbursement Agreement

See “Note 13. Commitments and Contingencies” of Notes to Consolidated Interim Financial Statements of this Form 10-Q for a discussion of environmental and other litigation matters.

Recent Accounting Pronouncements

See “Note 2. Summary of Significant Accounting Policies” of Notes to Consolidated Interim Financial Statements of this Form 10-Q for a discussion of recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from foreign currency exchange rates and interest rates, which could affect operating results, financial position and cash flows. We manage our exposure to these market risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments.

Interest Rate Risk

As of September 26, 2020, $942 million of our total debt of $1,322 million carried variable interest rates. The fair market values of our fixed-rate financial instruments are sensitive to changes in interest rates. At September 26, 2020, an increase or decrease in interest rate on our term loans and revolving credit facility by 100 basis points would have an approximate $10 million impact on our annual interest expense on debt.

Foreign Currency Exchange Rate Risk

We are exposed to market risks from changes in currency exchange rates. While we primarily transact with customers in the U.S. Dollar, we also transact in foreign currencies, primarily including the Euro, British Pound, Canadian Dollar, and Czech Koruna. These exposures may impact total assets, liabilities, future earnings and/or operating cash flows. Our exposure to market risk for changes in foreign currency exchange rates arises from transactions arising from international trade, foreign currency denominated monetary assets and liabilities, and international financing activities between subsidiaries. We rely primarily on natural offsets to address our exposures and may supplement this approach from time to time by entering into forward and option hedging contracts. As of September 26, 2020 and December 31, 2019 we have no outstanding hedging arrangements.

Commodity Price Risk

While we are exposed to commodity price risk, we attempt to pass through significant changes in component and raw material costs to our customers based on the contractual terms of our arrangements. In limited situations, we may not be fully compensated for such changes in costs.

34

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to give reasonable assurance that information required to be disclosed in the Company’s reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to management to allow timely decisions regarding required disclosures.

Management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Because there are inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud have been or will be detected.

Our Chief Executive Officer and Chief Financial Officer, with the assistance of other members of our management, including our Chief Accounting Officer, conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective at a reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended September 26, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

35

PART II

Item 1. Legal Proceedings

See “Note 13. Commitments and Contingencies — Other Matters” of Notes to Consolidated Interim Financial Statements of this Form 10-Q for a discussion on legal proceedings.

Item 1A. Risk Factors

We face a variety of risks that are inherent in our business and our industry, including operational, legal and regulatory risks. Such risks could cause our actual results to differ materially from our forward-looking statements, expectations and historical trends. There have been no material changes to the risk factors described in our 2019 Annual Report on Form 10-K, except as reflected in the two revised risk factors and one additional risk factor set forth below.

Our business, results of operations, financial condition, cash flows and stock price may be materially adversely impacted by pandemics, epidemics or other public health emergencies, such as the coronavirus (COVID-19) outbreak.

Our business, results of operations, financial condition, cash flows and stock price may be adversely affected by pandemics, epidemics or other public health emergencies, such as the COVID-19 virus, which has been characterized by the World Health Organization as a pandemic. This outbreak has negatively impacted and could continue to negatively impact the global economy. Our operating results will be subject to fluctuations based on general economic conditions and the extent to which COVID-19 may ultimately impact our business will depend on future developments, which are uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease and the duration of the outbreak and business closures or business disruptions for our Company, our suppliers and our customers. We have experienced, and may experience in the future, shutdowns affecting our key manufacturing sites due to regional health and safety reasons. While we continue to comply with all applicable health and sanitation requirements, we cannot ensure uninterrupted operations in areas impacted by COVID-19.

Deterioration in economic conditions could reduce our sales and profitability. Any financial distress of our customers due to deterioration in economic conditions could result in reduced sales and decreased collectability of accounts receivable which would negatively impact our results of operations. We also expect business conditions to remain challenging throughout the duration of the pandemic. The COVID-19 outbreak has had, and could continue to have an impact on our ability to obtain certain of the raw materials, parts and components we need to manufacture our products as our suppliers face disruptions in their businesses, including closures and potential bankruptcy as a result of the COVID-19 outbreak. We depend greatly on our suppliers for items that are essential to the manufacturing of our products. If our suppliers fail to meet our manufacturing needs, it could delay our production and our product shipments to customers and negatively affect our operations.

Should the adverse impacts described above (or others that are currently unknown) occur, whether individually or collectively, we could experience declines in revenues and profitability, as we have experienced in the second quarter. A prolonged period of such declines, including any impacts arising out of related general economic downtowns, could, among other things, exhaust our available liquidity (and ability to access liquidity sources) and/or trigger an acceleration to pay a significant portion or all of our then-outstanding debt obligations, which we may be unable to do.

The impact of a pandemic like COVID-19 can be mitigated by measures that international, federal, state, and local governments, agencies, law enforcement, and/or health authorities implement to address it. However, efforts to lift restrictions on individuals’ daily activities and businesses’ normal operations may result in spikes in cases related to the pandemic and potentially prolong and intensify the impact of the crisis. While the economic impact of COVID-19 may be reduced by financial assistance under the Coronavirus Aid, Relief, and Economic Security (CARES) Act or other similar COVID-19 related federal and state programs, such programs have not had a material impact on our business.

36

To the extent the COVID-19 outbreak adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in the risk factors included in the Annual Report on Form 10-K for the year ended December 31, 2019, including the following captioned risks described in such Annual Report:

“Disruption, or the need to relocate any of our facilities, could significantly disrupt our business;” “We rely on certain suppliers of materials and components for our product;” “We are subject to the economic, political, health, epidemic, regulatory, foreign exchange and other risks of international operations;” “Our operations require substantial capital and we may not be able to obtain additional capital that we need in the future on favorable terms or at all;” “Market and economic conditions may adversely affect the economic conditions of our customers, demand for our products and services and our results of operations;” “We have credit exposure to our customers;” “The commercial and credit environment may adversely affect our access to capital.”

We have experienced significant management turnover.

In November 2019, we announced the departure of our former Chief Financial Officer, and the appointment of an Interim Chief Financial Officer. In December 2019, we announced that the Board was conducting a search for a successor for our Chief Executive Officer. In January 2020, the Board appointed Sach Sankpal as our new President of Products & Solutions. On May 19, 2020, we announced the appointment of Jay Geldmacher as our new Chief Executive Officer and member of the board of directors. On May 29, 2020 we further announced the appointment of Tony Trunzo as our Executive Vice President and Chief Financial Officer. On October 13, 2020 the Company filed an 8-K which provided information about the departure of Sach Sankpal as President of the Products & Solutions segment and the appointment of Phil Theodore as President of the Products & Solutions segment. We are required to pay significant amounts of severance in connection with certain of these management transitions. Transitions in senior executive leadership can adversely affect relationships with our clients, suppliers, and employees, make it difficult to attract and retain talent and disrupt execution of our strategy and our efforts to enhance our operations. Changes in other key management positions may temporarily affect our financial performance and results of operations as the new management becomes familiar with our business. Accordingly, our future financial performance will depend to a significant extent on our ability to motivate and retain key management personnel.

We cannot predict with certainty the outcome of litigation matters, government proceedings and other contingencies and uncertainties.

In the ordinary course of business, we may make certain commitments, including representations, warranties and indemnities relating to current and past operations, including those related to divested businesses, and issue guarantees of third-party obligations. We are also subject to various lawsuits, investigations and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters.

In particular, the Company, the Company’s former CEO Michael Nefkens, the Company’s former CFO Joseph Ragan, and the Company’s former CIO Niccolo de Masi are named defendants of a purported class action securities suit styled In re Resideo Technologies, Inc. Securities Litigation, 19-cv-02863 (the “Securities Litigation”). The Securities Litigation is a class action securities suit with the class defined as all persons or entities who purchased or otherwise acquired common stock of Resideo during the class period of October 29, 2018 to November 6, 2019. The complaint asserts claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, broadly alleging, among other things, that the defendants (or some of them) made false and misleading statements regarding, among other things, Resideo’s business, performance, the efficiency of its supply chain, operational and administrative issues resulting from the spin-off from Honeywell, certain business initiatives, and financial guidance in 2019. The defendants filed a motion to dismiss the complaint on July 10, 2020.  We expect the motion to dismiss to be fully briefed in November 2020. A tentative argument is scheduled for December 1, 2020. See “Note 19. Commitments and Contingencies” of Notes to Consolidated and Combined Financial Statements in our 2019 Annual Report on Form 10-K for further discussion. The Company intends to vigorously defend against the allegations in the Securities Litigation, but there can be no assurance that the defense will be successful.

37

On July 7, 2020, Jawad A. Ayaz as Trustee of the Shiv Venkatasetty 2016 Trust (“Derivative Plaintiff”) filed a shareholder derivative complaint (the “Derivative Complaint”) against certain current or former directors and officers of the Company (“Derivative Defendants”) in the District Court for the District of Delaware, captioned Ayaz v. Nefkens, 20-cv-00915. Derivative Plaintiff alleges generally that Derivative Defendants breached fiduciary duties owed to the Company by allegedly causing or allowing the Company to make materially false and misleading statements to the public regarding the Company’s business operations and financial prospects. Derivative Plaintiff also alleges that the Company’s 2019 proxy statement was materially false and misleading, in violation of Section 14(a) of the Securities Exchange Act of 1934, and asserts claims of corporate waste and unjust enrichment, among other allegations, and relies on a similar set of facts as alleged in the Securities Litigation. The Derivative Complaint seeks declaratory relief and unspecified money damages on behalf of the Company. On July 28, 2020, certain of the Derivative Defendants filed a stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation. An additional shareholder derivative complaint was filed on August 12, 2020, by Plaintiff Daniel Sanclemente (the “Sanclemente Action”) on behalf of the Company in the District Court for the District of Delaware, captioned Sanclemente v. Nefkens, 20-cv-1062, alleging substantially the same facts and making substantially the same claims against the same defendants as in the Derivative Complaint. The parties to the Derivative Complaint and the Sanclemente Action have agreed to consolidate both actions. The consolidated action is styled In re Resideo Technologies, Inc. Derivative Litigation, 20-cv-00915 (the “Derivative Action”), and lead counsel has been appointed. Additionally, the pending stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation was granted and is applicable to the consolidated action. On August 28, 2020, Riviera Beach Police Pension Fund (“Riviera Beach”) filed a motion to intervene in the Derivative Action, noticing its intent to file a complaint against some or all of the Derivative Defendants. As of September 18, 2020, Riviera Beach and the existing plaintiffs reached an agreement regarding the leadership structure of the Derivative Action in the event that Riviera Beach files its own complaint. The Company intends to defend this action vigorously, but there can be no assurance that the defense will be successful.

We are unable to predict how long such proceedings, in particular the purported class action and derivative lawsuits, will continue, but we anticipate that we may incur significant costs in connection with some or all of these matters and that these proceedings and any related matters may result in a substantial distraction of management’s time. In addition, we are and could, in the future, face additional legal proceedings and investigations and inquiries by governmental agencies relating to these or similar matters. Our potential liabilities are subject to change over time due to new developments, changes in settlement strategy or the impact of evidentiary requirements, and we may become subject to or be required to pay damage awards or settlements that could have an adverse effect on our business, financial condition, results of operations and cash flows. If we were required to make payments, such payments could be significant and could exceed the amounts we have accrued with respect thereto, adversely affecting our business, financial condition, results of operations and cash flows. While we maintain or may otherwise have access to insurance for certain risks, the amount of our insurance coverage may not be adequate to cover the total amount of all insured claims and liabilities and we may have to satisfy insurance retentions. The incurrence of significant liabilities for which there is no or insufficient insurance coverage (or where there is available insurance but high retention levels) could adversely affect our liquidity and financial condition, results of operations and cash flows.

38

Item 6. Exhibits

The Exhibits listed below on the Exhibit Index are filed or incorporated by reference as part of this Form 10-Q.

EXHIBIT INDEX

Exhibit Number	Exhibit Description
2.1	Second Amendment to Indemnification and Reimbursement Agreement, dated as of July 28, 2020, between Resideo Intermediate Holding Inc. and Honeywell International Inc. (incorporated by reference to Exhibit 2.1 to Resideo's Form 8-K filed July 31, 2020)
31.1	Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
31.2	Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.1	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
101.INS	Inline XBRL Instance Document (filed herewith)
101.SCH	Inline XBRL Taxonomy Extension Schema (filed herewith)
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase (filed herewith)
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase (filed herewith)
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase (filed herewith)
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase (filed herewith)
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

39

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Resideo Technologies, Inc.
Date: November 5, 2020	By:	/s/ Anthony L. Trunzo
		Anthony L. Trunzo Executive Vice President and Chief Financial Officer (on behalf of the Registrant and as the Registrant’s Principal Financial Officer)

Date: November 5, 2020	By:	/s/ AnnMarie Geddes
		AnnMarie Geddes Vice President, Controller and Chief Accounting Officer  (Principal Accounting Officer)

40

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Jay Geldmacher, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Resideo Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2020	By:	/s/Jay Geldmacher
		Jay Geldmacher
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Anthony L. Trunzo, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Resideo Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2020	By:	/s/Anthony L. Trunzo
		Anthony L. Trunzo
		Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Resideo Technologies, Inc. (the Company) on Form 10-Q for the period ended  September 26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Jay Geldmacher, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2020	By:	/s/ Jay Geldmacher
		Jay Geldmacher
		President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Resideo Technologies, Inc. (the Company) on Form 10-Q for the period ended  September 26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Anthony L. Trunzo, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 5, 2020	By:	/s/ Anthony L. Trunzo
		Anthony L. Trunzo
		Executive Vice President and Chief Financial Officer

XML

Document And Entity Information - shares	9 Months Ended
	Sep. 26, 2020	Nov. 02, 2020
Cover [Abstract]
Document Type	10-Q
Document Period End Date	Sep. 26, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Trading Symbol	REZI
Entity Registrant Name	Resideo Technologies, Inc.
Entity Central Index Key	0001740332
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		123,494,919
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Title of 12(b) Security	Common Stock
Security Exchange Name	NYSE
Entity File Number	001-38635
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-5318796
Entity Address, Address Line One	901 E 6th Street
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78702
City Area Code	512
Local Phone Number	726-3500
Document Quarterly Report	true
Document Transition Report	false

XML

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Income Statement [Abstract]
Net revenue	$ 1,362	$ 1,226	$ 3,570	$ 3,684
Cost of goods sold	992	917	2,680	2,720
Gross profit	370	309	890	964
Selling, general and administrative expenses	239	250	731	778
Operating profit	131	59	159	186
Other expense, net	35	35	106	54
Interest expense	14	16	49	51
Income before taxes	82	8	4	81
Tax expense	7		26	36
Net income (loss)	$ 75	$ 8	$ (22)	$ 45
Weighted Average Number of Common Shares Outstanding (in thousands)
Basic	123,421	122,770	123,194	122,681
Diluted	125,235	123,244	123,194	123,404
Earnings (Loss) Per Share
Basic	$ 0.61	$ 0.07	$ (0.18)	$ 0.37
Diluted	$ 0.60	$ 0.06	$ (0.18)	$ 0.36

XML

CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 75	$ 8	$ (22)	$ 45
Other comprehensive income (loss), net of tax
Foreign exchange translation adjustment	28	(35)	6	(33)
Total other comprehensive income (loss), net of tax	28	(35)	6	(33)
Comprehensive income (loss)	$ 103	$ (27)	$ (16)	$ 12

XML

CONSOLIDATED INTERIM BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 260	$ 122
Accounts receivable – net	884	817
Inventories – net	618	671
Other current assets	161	175
Total current assets	1,923	1,785
Property, plant and equipment – net	311	316
Goodwill	2,657	2,642
Other assets	378	385
Total assets	5,269	5,128
Current liabilities:
Accounts payable	858	920
Current maturities of debt	181	22
Accrued liabilities	606	552
Total current liabilities	1,645	1,494
Long-term debt	1,141	1,158
Obligations payable under Indemnification Agreements	586	594
Other liabilities	292	280
COMMITMENTS AND CONTINGENCIES (Note 13)
EQUITY
Common stock, $0.001 par value, 700,000 shares authorized, 124,324 and 123,443 shares issued and outstanding as of September 26, 2020, 123,488 and 122,873 shares issued and outstanding as of December 31, 2019, respectively	0	0
Additional paid-in capital	1,782	1,761
Treasury stock, at cost	(5)	(3)
Retained earnings	16	38
Accumulated other comprehensive (loss)	(188)	(194)
Total equity	1,605	1,602
Total liabilities and equity	$ 5,269	$ 5,128

XML

CONSOLIDATED INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 26, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	124,324,000	123,488,000
Common stock, shares outstanding	123,443,000	122,873,000

XML

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions		9 Months Ended
		Sep. 26, 2020	Sep. 28, 2019
Cash flows provided by (used for) operating activities:
Net (loss) income		$ (22)	$ 45
Adjustments to reconcile net (loss) income to net cash provided by (used for) operating activities:
Depreciation and amortization		64	55
Restructuring charges, net of payments		4	12
Stock compensation expense	[1]	21	22
Other		20	10
Changes in assets and liabilities:
Accounts receivable		(64)	(27)
Inventories – net		64	(109)
Other current assets		15	(13)
Accounts payable		(62)	(23)
Accrued liabilities		48	(6)
Obligations payable under Indemnification Agreements		(8)	(49)
Other		12	13
Net cash provided by (used for) operating activities		92	(70)
Cash flows used for investing activities:
Expenditures for property, plant, equipment and other intangibles		(50)	(66)
Cash paid for acquisitions, net of cash acquired		(35)	(17)
Net cash used for investing activities		(85)	(83)
Cash flows provided by financing activities:
Net proceeds from revolving credit facility		150	60
Repayment of long-term debt		(11)	(11)
Non-operating obligations paid to Honeywell, net		(2)	(24)
Tax payments related to stock vestings		(2)	(3)
Net cash provided by financing activities		135	22
Effect of foreign exchange rate changes on cash and cash equivalents		(4)	(2)
Net increase (decrease) in cash and cash equivalents		138	(133)
Cash and cash equivalents at beginning of period		122	265
Cash and cash equivalents at end of period		$ 260	$ 132

[1] Stock compensation expense adjustment includes only non-cash expenses.

XML

CONSOLIDATED INTERIM STATEMENTS OF EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Treasury Shares	Additional Paid-In Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2018	$ 1,533			$ 1,720	$ 2	$ (189)
Beginning Balance, Shares at Dec. 31, 2018		122,499,000	468,000
Net income (loss)	45				45
Other comprehensive (loss) income, net of tax	(33)					(33)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes	(3)		$ (3)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes, Shares		287,000	128,000
Stock-based compensation	22			22
Adjustments due to Spin-Off	9			9
Ending Balance at Sep. 28, 2019	1,573		$ (3)	1,751	47	(222)
Ending Balance, Shares at Sep. 28, 2019		122,786,000	596,000
Beginning Balance at Jun. 29, 2019	1,593		$ (2)	1,743	39	(187)
Beginning Balance, Shares at Jun. 29, 2019		122,710,000	558,000
Net income (loss)	8				8
Other comprehensive (loss) income, net of tax	(35)					(35)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes	(1)		$ (1)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes, Shares		76,000	38,000
Stock-based compensation	8			8
Ending Balance at Sep. 28, 2019	1,573		$ (3)	1,751	47	(222)
Ending Balance, Shares at Sep. 28, 2019		122,786,000	596,000
Beginning Balance at Dec. 31, 2019	1,602		$ (3)	1,761	38	(194)
Beginning Balance, Shares at Dec. 31, 2019		122,873,000	615,000
Net income (loss)	(22)				(22)
Other comprehensive (loss) income, net of tax	6					6
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes	(2)		$ (2)
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes, Shares		570,000	266,000
Stock-based compensation	21			21
Ending Balance at Sep. 26, 2020	1,605		$ (5)	1,782	16	(188)
Ending Balance, Shares at Sep. 26, 2020		123,443,000	881,000
Beginning Balance at Jun. 27, 2020	1,495		$ (5)	1,775	(59)	(216)
Beginning Balance, Shares at Jun. 27, 2020		123,378,000	852,000
Net income (loss)	75				75
Other comprehensive (loss) income, net of tax	28					28
Issuance of common stock under stock-based compensation plans, net of shares withheld for employee taxes, Shares		65,000	29,000
Stock-based compensation	7			7
Ending Balance at Sep. 26, 2020	$ 1,605		$ (5)	$ 1,782	$ 16	$ (188)
Ending Balance, Shares at Sep. 26, 2020		123,443,000	881,000

XML

Organization, Consolidation and Presentation of Financial Statements

9 Months Ended

Sep. 26, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Organization, Operations and Basis of Presentation

Note 1. Organization, Operations and Basis of Presentation

Business Description

Resideo Technologies, Inc. (“Resideo” or “the Company”), is a global provider of products, software, solutions and technologies that help homeowners stay connected and in control of their comfort, security and energy use. The Company is a leader in the home heating, ventilation and air conditioning controls and security markets, and a leading global distributor of low-voltage electronic and security products.

The Company was incorporated in Delaware on April 24, 2018. The Company separated from Honeywell International Inc. (“Honeywell”) on October 29, 2018, becoming an independent publicly traded company as a result of a pro rata distribution of the Company’s common stock to shareholders of Honeywell (the “Spin-Off”).

Basis of Presentation

The Company’s financial statements are presented on a consolidated basis (collectively, the “Interim Financial Statements”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany transactions have been eliminated for all periods presented. The Interim Financial Statements are unaudited; however, in the opinion of management, they contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

In periods subsequent to the Spin-Off, we have made adjustments to balances transferred at the Spin-Off, including adjustments to the classification of assets or liabilities transferred. Any such adjustments are recorded directly to equity in Adjustments due to the Spin-Off and are considered immaterial.

The Company reports financial information on a fiscal quarter basis using a “modified” 4-4-5 calendar (modified in that the fiscal year always begins on January 1 and ends on December 31) that requires its businesses to close their first, second and third quarter books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. In the event that differences in closing dates are material to year-over-year comparisons of quarterly or year-to-date results, the Company will provide appropriate disclosures.

Reclassification 

On January 1, 2020, the Company changed its classification of research and development expenses in the Consolidated Interim Statements of Operations from Cost of goods sold to Selling, general and administrative expenses, such that research and development expenses are excluded from the calculation of Gross profit. The impact on the September 28, 2019 Consolidated Interim Statement of Operations is a reduction of Cost of goods sold, an increase in Gross profit and an increase in Selling, general and administrative expenses for the three and nine months ended September 28, 2019 of $20 million and $66 million, respectively. The impact of the reclassification for the three and nine months ended September 28, 2019 is also reflected in “Note 6. Restructuring and Other Charges”. This reclassification had no effect on the previously reported Net income (loss) or the Company’s Consolidated Interim Statements of Comprehensive Income (Loss), Consolidated Interim Statements of Cash Flows, or Consolidated Interim Balance Sheets.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 26, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

The Company’s accounting policies are set forth in “Note 2. Summary of Significant Accounting Policies” of the Company’s Notes to Consolidated and Combined Financial Statements included in the 2019 Annual Report on Form 10-K. Included herein are certain updates to those policies.

The World Health Organization (“WHO”) declared the novel coronavirus disease ("COVID-19") a pandemic in March 2020. Starting at the end of the first quarter and throughout the second quarter, the Company experienced constrained supply and slowed customer demand that adversely impacted the Company’s business, results of operations and overall financial performance. Although there remains uncertainty as to the continuing implications of COVID-19, during the third quarter customer demand improved and cost actions taken during the first half of the year contributed to improvements in the Company’s results of operations and overall financial performance. As there remains uncertainty around the impacts of the COVID-19 pandemic, the Company addresses and evaluates the impacts frequently. At September 26, 2020, the Company believes that the accounting policies most likely to be affected by the COVID-19 pandemic are the following:

Use of Estimates—The preparation of the Company’s Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the Consolidated Financial Statements and related disclosures in the accompanying Notes to Consolidated Financial Statements. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed, and the effects of changes are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Estimates are used when accounting for stock-based compensation, pension benefits, contingent consideration, indemnification liabilities, goodwill and intangible assets, and valuation allowances for accounts receivable, inventory, deferred tax assets, and the amounts of revenue and expenses reported during the period. The Company has used information available to identify potential impacts caused by the COVID-19 pandemic at September 26, 2020 in these estimates.

Goodwill— The Company has determined that it is likely that the carrying value of goodwill exceeds the fair value at September 26, 2020. However, the extent to which COVID-19 may adversely impact our business depends on future developments, which are uncertain and unpredictable, depending upon the severity and duration of the outbreak, and the effectiveness of actions taken globally to contain or mitigate its effects. Any resulting financial impact cannot be estimated reasonably at this time but may adversely affect our business and financial results. It is likely that, during the remainder of 2020 and into 2021, macroeconomic conditions will be volatile and could impact our business. If there is an adverse change in facts and circumstances, then an impairment charge may be necessary in the future. Specifically, the fair value of our Products & Solutions reporting unit, with goodwill of approximately $2,012 million at September 26, 2020, exceeded its' carrying value by 10% in the 2019 annual impairment test and therefore is highly sensitive to adverse changes in the facts and circumstances that could result in a possible future impairment. Should the fair value of the Company’s reporting units fall below its' carrying amount because of reduced operating performance, market declines, changes in the discount rate, a more significant impact than expected from the COVID-19 pandemic, or other conditions, charges for impairment may be necessary. The Company regularly monitors its reporting units to determine if there is an indicator of potential impairment. The Company will perform its annual goodwill impairment assessment during the fourth quarter.

Recent Accounting Pronouncements—The Company considers the applicability and impact of all recent accounting standards updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial position or results of operations.

In August 2018, the FASB issued guidance that amends the current disclosure requirements regarding defined benefit pensions and other post retirement plans and allows for the removal of certain disclosures, while adding certain new disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2020 and allows for early adoption. The Company will adopt on January 1, 2021 and does not expect this new standard to have a significant impact to its disclosures.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by, among other things, eliminating certain existing exceptions related to the general approach in ASC 740 relating to franchise taxes, reducing complexity in

the interim-period accounting for year-to-date loss limitations and changes in tax laws, and clarifying the accounting for transactions outside of business combinations that result in a step-up in the tax basis of goodwill. The transition requirements are primarily prospective and the effective date for Resideo is January 1, 2021, with early adoption permitted. The Company early adopted the provisions of this guidance on January 1, 2020. Adoption of this guidance did not have a material financial statement impact.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which is optional guidance related to reference rate reform that provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our Term Loans and Revolving Credit Facility, which use LIBOR as a reference rate, and is effective immediately, but is only available through December 31, 2022. Refer to “Note 10. Long-term Debt and Credit Agreement” for further details on our Term Loans and Revolving Credit Facility. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

XML

Earnings (Loss) Per Share

9 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

Earnings (Loss) Per Share

Note 3. Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in millions except shares in thousands and per share data):

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Shares used in computing basic earnings per share		123,421		122,770		123,194			122,681
Effect of dilutive securities:
Dilutive effect of common stock equivalents		1,814		474		-			723
Shares used in computing diluted earnings per share		125,235		123,244		123,194			123,404
Earnings (loss) per share:
Basic	$	0.61	$	0.07	$	(0.18	)	$	0.37
Diluted	$	0.60	$	0.06	$	(0.18	)	$	0.36

Diluted earnings per share is computed based upon the weighted average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the three and nine months ended September 26, 2020 and September 28, 2019. In periods where the Company has a net loss, no dilutive common shares are included in the calculation for diluted shares as they are considered anti-dilutive. For the three and nine months ended September 26, 2020, average options and other rights to purchase approximately 1.1 million and 3.6 million shares of common stock, respectively, were outstanding, all of which were anti-dilutive during the three and nine months ended September 26, 2020, and therefore excluded from the computation of diluted earnings per common share. In addition, an average of approximately 0.8 million and 0.6 million shares of performance-based unit awards are excluded from the computation of diluted earnings per common share for the three and nine months ended September 26, 2020 as the contingency has not been satisfied. For the three and nine months ended September 28, 2019, options and other rights to purchase approximately 3.8 million and 1.5 million shares of common stock, respectively, were outstanding, all of which were anti-dilutive during the three and nine months ended September 28, 2019, and therefore excluded from the computation of diluted income per common share. An average of approximately 0.3 million shares of performance-based unit awards are excluded from the computation of diluted earnings per common share for the three and nine months ended September 28, 2019, as the contingency has not been satisfied.

XML

Acquisitions

9 Months Ended

Sep. 26, 2020

Business Combinations [Abstract]

Acquisitions

Note 4. Acquisitions

On February 10, 2020, the Company completed the acquisition of privately held Herman ProAV, a leading provider and distributer of professional audio-visual products, procurement services and labor resources to systems integrators in the commercial audio-visual industry. The purchase price paid for this acquisition was approximately $36 million. In connection with this acquisition, the Company recognized goodwill and intangible assets of $4 million and $18 million, respectively. This acquisition was integrated into and builds upon ADI Global Distribution’s product portfolio and expands its presence in the pro-AV market. The Herman ProAV acquisition agreements include deferred payments for certain individuals that are contingent upon employment as well as financial performance. The Company determined that these deferred payments are accounted for as compensation expense over the requisite service period. The Company is substantially complete with the allocation of purchase price, however, amounts are still subject to finalization. Pro-forma disclosures are not provided as the acquisition has an immaterial financial statement impact.

XML

Revenue Recognition

9 Months Ended

Sep. 26, 2020

Revenue From Contract With Customer [Abstract]

Revenue Recognition

Note 5. Revenue Recognition

Disaggregated Revenue

Revenues by geography and business line are as follows:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Comfort	$	297	$	256	$	725	$	799
Security		142		128		379		397
Residential Thermal Solutions		133		128		341		404
Products & Solutions		572		512		1,445		1,600
U.S. and Canada		650		590		1,758		1,705
EMEA (1)		129		109		338		336
APAC (2)		11		15		29		43
ADI Global Distribution		790		714		2,125		2,084
Net revenue	$	1,362	$	1,226	$	3,570	$	3,684

(1) EMEA represents Europe, the Middle East and Africa.

(2) APAC represents Asia and Pacific countries.

The Company recognizes the majority of its revenue from performance obligations outlined in contracts with its customers that are satisfied at a point in time. Approximately 3% of the Company’s revenue is satisfied over time. As of September 26, 2020 and September 28, 2019, contract assets and liabilities were not material. 

XML

Restructuring and Other Charges

9 Months Ended

Sep. 26, 2020

Restructuring And Related Activities [Abstract]

Restructuring and Other Charges

Note 6. Restructuring and Other Charges

During the fourth quarter of 2019, the Company announced commencement of a comprehensive financial and operational review focused on product cost, gross margin improvement, and general and administrative expense simplification. The review is being overseen by the Strategic and Operational Committee of the board, comprised of independent directors. The Company retained industry-recognized experts in supply chain optimization and organizational excellence to assist in the review. Certain restructuring actions have been and are continuing to be implemented under this program as well as previous programs. Products & Solutions segment restructuring and related expenses for the three and nine months ended September 26, 2020 were $7 million and $24 million, respectively, and for the three and nine months ended September 28, 2019, restructuring and related expense were $9 million and $28 million, respectively. ADI Global Distribution segment restructuring and related expenses for the three and nine months ended September 26, 2020 were $0 million and $3 million, respectively, and for the three and nine months ended September 28, 2019, restructuring and related expenses were $0 million and $6 million, respectively. Restructuring and related expenses for all periods are primarily related to severance.

The Company's restructuring expenses for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	2	$	4	$	7	$	11
Selling, general and administrative expenses		5		5		20		23
	$	7	$	9	$	27	$	34

The following table summarizes the status of total restructuring reserves related to severance cost included in Accrued liabilities in the unaudited Consolidated Balance Sheets: 

	Nine Months Ended
	September 26,
	2020
Beginning of period	$	19
Charges		27
Usage – cash payments		(23	)
End of period	$	23

XML

Income Taxes

9 Months Ended

Sep. 26, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Note 7. Income Taxes

The Company recorded a tax expense of $7 million and $26 million for the three and nine months ended September 26, 2020, respectively.

For interim periods, income tax is equal to the total of (1) year-to-date pretax income multiplied by our forecasted effective tax rate plus (2) tax expense items specific to the period. In situations where we expect to report losses for which we do not expect to receive tax benefits, we are required to apply separate forecasted effective tax rates to those jurisdictions rather than including them in the consolidated forecasted effective tax rate.

For the three months ended September 26, 2020, the net tax expense of $7 million was driven by interim period tax expense of $7 million based on year-to-date actual amounts. Tax expense specific to the period was $0. In addition to items specific to the period, our income tax rate is impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

For the nine months ended September 26, 2020, net tax expense of $26 million consisted primarily of interim period tax expense of $11 million based on year-to-date actual amounts, and tax expense specific to the period of approximately $15 million, consisting primarily of $15 million for valuation allowances in foreign jurisdictions, $2 million related to the estimated tax impact of the CARES Act on prior years, and share-based excess cost of $1 million, partially offset by a $3 million tax benefit for changes in estimates related to prior years. In addition to items specific to the period, our income tax rate is impacted by the mix of earnings across the jurisdictions in which we operate, non-deductible expenses, and U.S. taxation of foreign earnings.

XML

Inventories Net

9 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

Inventories Net

Note 8. Inventories—Net

	September 26,			December 31,
	2020			2019
Raw materials	$	156		$	154
Work in process		20			18
Finished products		521			568
Inventory reserves		(79	)		(69	)
	$	618		$	671

XML

Accrued Liabilities

9 Months Ended

Sep. 26, 2020

Payables And Accruals [Abstract]

Accrued Liabilities

Note 9. Accrued Liabilities

	September 26,		December 31,
	2020		2019
Obligations payable under Indemnification Agreements	$	175	$	140
Taxes payable		53		66
Compensation, benefit and other employee-related		82		66
Customer rebate reserve		71		78
Other		225		202
	$	606	$	552

Refer to “Note 13. Commitments and Contingencies” for further details on Obligations payable under Indemnification Agreements.

XML

Long-term Debt and Credit Agreement

9 Months Ended

Sep. 26, 2020

Debt Disclosure [Abstract]

Long-term Debt and Credit Agreement

Note 10. Long-term Debt and Credit Agreement

The Company’s debt at September 26, 2020 and December 31, 2019 consisted of the following:

	September 26,			December 31,
	2020			2019
6.125% notes due 2026	$	400		$	400
Five-year variable rate term loan A due 2023		324			333
Seven-year variable rate term loan B due 2025		468			470
Revolving Credit Facility		150			-
Unamortized deferred financing costs and debt discounts		(20	)		(23	)
Total outstanding indebtedness		1,322			1,180
Less: amounts due within one year		181			22
Total long-term debt due after one year	$	1,141		$	1,158

On November 26, 2019, the Company entered into a First Amendment to the Credit Agreement (the “Credit Agreement Amendment”). The Credit Agreement Amendment amended the five-year variable rate term loan A due 2023 (the “Term A Loan Facility”), the seven-year variable rate term loan B due 2025 (the “Term B Loan Facility” and together, the “Term Loans”) and the five-year senior secured first-lien revolving credit facility (the “Revolving Credit Facility”) credit agreement (the “Credit Agreement”) to, among other things: (i) increase the levels of the maximum consolidated total leverage ratio under the Credit Agreement, to not greater than 5.25 to 1.00 for the quarter ended December 31, 2019, with step-downs to 4.75 to 1.00 starting in the quarter ending December 31, 2020, 4.25 to 1.00 starting in the quarter ending December 31, 2021, and 3.75 to 1.00 starting in the quarter ending December 31, 2022; (ii) increase each applicable interest rate margin on loans outstanding after the Credit Agreement Amendment effective date by 25 basis points per annum, 2.25% per annum (for LIBOR loans) and 1.25% per annum (for ABR loans) in respect of the Term B Loan Facility, and based on our leverage ratio, from 2.25% per annum to 1.75% per annum (for LIBOR loans) and 1.25% to 0.75% per annum (for ABR loans) for the Term A Loan Facility and the Revolving Credit Facility; and (iii) modify the defined terms “Consolidated EBITDA” and “Pro Forma Basis” set forth in the Credit Agreement.

As of September 26, 2020, there were $150 million of borrowings and no letters of credit issued under the Revolving Credit Facility. The Company assessed the amount recorded under the Term Loans, the 6.125% senior unsecured notes (the “Senior Notes”), and the Revolving Credit Facility. The Company determined that the Revolving Credit Facility approximated fair value. The Term A Loan Facility, Term B Loan Facility and the Senior Notes’ fair values are approximately $307, $460 and $395 million, respectively. The fair values of the debt are based on the quoted inactive prices and are therefore classified as Level 2 within the valuation hierarchy.

At September 26, 2020, the interest rate for the Term Loans was 2.56% and the weighted average interest rate for the Revolving Credit Facility was 2.41%.

For more information, please refer to “Note 15. Long-term Debt and Credit Agreement” in our 2019 Annual Report on Form 10-K.

XML

Leases

9 Months Ended

Sep. 26, 2020

Leases [Abstract]

Leases

Note 11. Leases

The Company is party to operating leases for the majority of its manufacturing sites, offices, engineering and lab sites, stocking locations, warehouses, automobiles, and certain equipment. Certain of the Company’s real estate leases include variable rental payments which adjust periodically based on inflation, and certain automobile lease agreements include rental payments which fluctuate based on mileage. Generally, the Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company’s operating lease costs for the three and nine months ended September 26, 2020 and September 28, 2019 consisted of the following:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	5	$	4	$	13	$	12
Selling, general & administrative		13		10		33		27
Total operating lease costs	$	18	$	14	$	46	$	39

Total operating lease costs include variable lease costs of $5 million and $12 million, respectively, for the three and nine months ended September 26, 2020. For the three and nine months ended September 28, 2019, total operating lease costs included variable lease costs of $3 million and $8 million, respectively. Total operating lease costs also include offsetting sublease income which is immaterial for the three and nine months ended September 26, 2020 and September 28, 2019.

The Company recognized the following related to its operating leases:

	Financial Statement Line Item	At September 26, 2020		At December 31, 2019
Operating right-of-use assets	Other assets	$	134	$	137
Operating lease liabilities - current	Accrued liabilities	$	33	$	31
Operating lease liabilities - noncurrent	Other liabilities	$	109	$	111

Maturities of the Company’s operating lease liabilities were as follows:

	At September 26, 2020
2020	$	10
2021		39
2022		35
2023		28
2024		16
Thereafter		39
Total lease payments		167
Less: imputed interest		25
Present value of operating lease liabilities	$	142
Weighted-average remaining lease term (years)		5.44
Weighted-average incremental borrowing rate		6.00	%

Supplemental cash flow information related to the Company’s operating leases was as follows:

	Nine Months Ended
	September 26,		September 28,
	2020		2019
Operating cash outflows	$	22	$	28
Operating right-of-use assets obtained in exchange for operating lease liabilities	$	22	$	47

As of September 26, 2020, the Company has additional operating leases that have not yet commenced. Obligations under these leases are not material. Additionally, as a lessor, the Company leases all or a portion of certain owned properties. Rental income for the three and nine months ended September 26, 2020 and September 28, 2019 was not material.

XML

Stock-Based Compensation Plans

9 Months Ended

Sep. 26, 2020

Compensation Related Costs [Abstract]

Stock-Based Compensation Plans

Note 12. Stock-Based Compensation Plans

Restricted Stock Units (“RSUs”)

During the nine months ended September 26, 2020, as part of the Company’s annual long-term compensation under the 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates and the 2018 Stock Incentive Plan for Non-Employee Directors of Resideo Technologies, Inc. as may be amended from time to time (together, the “Stock Incentive Plan”), it granted 795,099 performance-based RSUs and 2,168,943 time-based RSUs to eligible employees. The weighted average grant date fair value per share for these shares was $9.18.

Stock Options

During the nine months ended September 26, 2020, as part of the Company’s annual long-term compensation under the Stock Incentive Plan, 1,083,665 stock options were granted to eligible employees at a weighted average exercise price per share of $9.17 and weighted average grant date fair value per share of $2.61.

XML

Commitments and Contingencies

9 Months Ended

Sep. 26, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 13. Commitments and Contingencies

Environmental Matters

The Company is subject to various federal, state, local and foreign government requirements relating to the protection of the environment and accrues costs related to environmental matters when it is probable that it has incurred a liability related to a contaminated site and the amount can be reasonably estimated. Environmental-related expenses for sites owned and operated by Resideo are presented within Cost of goods sold for operating sites. For the three and nine months ended September 26, 2020 and September 28, 2019, environmental expenses related to these operating sites were not material. Liabilities for environmental costs were $22 million as of September 26, 2020 and December 31, 2019.

The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to our unaudited consolidated results of operations and operating cash flows in the periods recognized or paid.

Obligations Payable Under Indemnification Agreements

In connection with the Spin-Off, the Company entered into an indemnification and reimbursement agreement with Honeywell (the "Reimbursement Agreement") and a tax matters agreement (the "Tax Matters Agreement") (collectively, the "Indemnification Agreements") which are further described below.

Reimbursement Agreement

On October 29, 2018, in connection with the Spin-Off, the Company entered into the Reimbursement Agreement with Honeywell pursuant to which the Company has an obligation to make cash payments to Honeywell in amounts equal to 90% of payments for certain Honeywell environmental-liability payments, which include amounts billed (“payments”), less 90% of Honeywell’s net insurance receipts relating to such liabilities, and less 90% of the net proceeds received by Honeywell in connection with (i) affirmative claims relating to such liabilities, (ii) contributions by other parties relating to such liabilities and (iii) certain property sales (the “recoveries”). The amount payable by the Company in respect of such liabilities arising in respect of any given year is subject to a cap of $140 million (exclusive of any late payment fees up to 5% per annum). The scope of the Company’s current environmental remediation obligations subject to the Reimbursement Agreement relates to approximately 230 sites or groups of sites that are undergoing environmental remediation under U.S. federal or state law and agency oversight for contamination associated with Honeywell historical business operations. The ongoing environmental remediation is designed to address contaminants at upland and sediment sites, which include, among others, metals, organic compounds and polychlorinated biphenyls, through a variety of methods, which include, among others, excavation, capping, in-situ stabilization, groundwater treatment and dredging. In addition, the Company obligations subject to the Reimbursement Agreement include certain liabilities with respect to (i) hazardous exposure or toxic tort claims associated with the specified sites that arise after the Spin-Off, if any, (ii) currently unidentified releases of hazardous substances at or associated with the specified sites, (iii) other environmental claims associated with the specified sites and (iv) consequential damages.

Payments in respect of the liabilities arising in a given year will be made quarterly throughout such year on the basis of an estimate of the liabilities and recoveries provided by Honeywell. Following the end of any such year, Honeywell will provide the Company with a calculation of the amount of payments and the recoveries actually received.

Payment amounts under the Reimbursement Agreement will be deferred to the extent that a specified event of default has occurred and is continuing under certain indebtedness, including under the Company’s Credit Agreement, or the payment thereof causes the Company to not be compliant with certain financial covenants in certain indebtedness, including the Company’s Credit Agreement, on a pro forma basis, including the maximum total leverage ratio (ratio of consolidated debt to consolidated EBITDA, which excludes any amounts owed under the Reimbursement Agreement), and the minimum interest coverage ratio. A 5% late payment fee will accrue on all amounts that are not otherwise entitled to be deferred under the terms of the Reimbursement Agreement, without prejudice to any other rights that Honeywell may have for late payments.

The obligations under the Reimbursement Agreement will continue until the earlier of: (1) December 31, 2043; or (2) December 31 of the third consecutive year during which the annual reimbursement obligation (including in respect of deferred payment amounts) has been less than $25 million.

On April 21, 2020, the Company and Honeywell entered into an amendment to the Reimbursement Agreement (the "Reimbursement Agreement Amendment"). Pursuant to the Reimbursement Agreement Amendment, certain covenants in Exhibit G of the Reimbursement Agreement were modified to conform, if applicable, to the amended covenants included in the Credit Agreement Amendment. In addition, under the Reimbursement Agreement Amendment, the parties agreed to defer until no later than July 30, 2020 (which was further amended as described below) the $35 million quarterly payment otherwise payable to Honeywell on April 30, 2020. The Reimbursement Agreement Amendment expressly reserves all rights of the parties thereto and their respective affiliates in respect of the Reimbursement Agreement and each other contract or agreement between such parties or their affiliates (the “Other Agreements”), and provides that the execution of the amendment does not constitute a waiver of any claims, rights, remedies, defenses, arguments, interpretations or obligations of such parties or their affiliates under or related to the Reimbursement Agreement or any Other Agreement.

On July 28, 2020, the Company and Honeywell entered into the Second Reimbursement Agreement Amendment. Pursuant to the Second Reimbursement Agreement Amendment, the parties agreed to further defer until no later than October 30, 2020 the $35 million quarterly payment that was originally due thirty days following the start of the second quarter of 2020 and was previously deferred until no later than July 30, 2020 pursuant to the Reimbursement Agreement Amendment. The deferred payment was made on October 30, 2020.

The following table summarizes information concerning our Reimbursement Agreement liabilities:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning balance	$	585		$	616
Accruals for indemnification liabilities deemed probable and reasonably estimable		107			138
Reduction (1)		-			(81	)
Indemnification payment		(70	)		(105	)
Ending balance (2)	$	622		$	568

(1) Reduction in indemnification liabilities relates to a provision in the Reimbursement Agreement that reduces the obligation due to Honeywell for any proceeds received by Honeywell from a property sale of a site under the agreement.

(2) Reimbursement Agreement liabilities deemed probable and reasonably estimable, however, it is possible the Company could pay $140 million per year (exclusive of any late payment fees up to 5% per annum) until the earlier of (1) December 31, 2043; or (2) December 31 of the third consecutive year during which the annual reimbursement obligation (including in respect of deferred payment amounts) has been less than $25 million.

For the three and nine months ended September 26, 2020, net expenses related to the Reimbursement Agreement were $38 million and $107 million, respectively, and for the three and nine months ended September 28, 2019, expenses related to the Reimbursement Agreement were $35 million and $57 million, respectively, and are recorded in Other expense, net. Reimbursement Agreement liabilities are included in the following balance sheet accounts:

	September 26, 2020		December 31, 2019
Accrued liabilities	$	175	$	140
Obligations payable under Indemnification Agreements		447		445
	$	622	$	585

The Company does not currently possess sufficient information to reasonably estimate the amounts of indemnification liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to our unaudited consolidated results of operations and operating cash flows in the periods recognized or paid.

Tax Matters Agreement

In connection with the Spin-Off, the Company entered into the Tax Matters Agreement with Honeywell pursuant to which it is responsible and will indemnify Honeywell for all taxes, including income taxes, sales taxes, VAT and payroll taxes, relating to the business for all periods, including periods prior to the consummation of the Spin-Off. As of September 26, 2020 and December 31, 2019, the Company had an indemnity outstanding to Honeywell for future tax payments of $139 million and $149 million, respectively, which is included in Obligations payable under Indemnification Agreements.

Trademark Agreement

In connection with the Spin-Off, the Company and Honeywell entered into a 40-year Trademark License Agreement (the “Trademark Agreement”) that authorizes the Company’s use of certain licensed trademarks in the operation of Resideo’s business for the advertising, sale and distribution of certain licensed products. In exchange, the Company pays a royalty fee of 1.5% on net revenue to Honeywell related to such licensed products which is recorded in Selling, general and administrative expense on the unaudited Consolidated Interim Statements of Operations. For the three and nine months ended September 26, 2020, royalty fees were $7 million and $18 million, respectively. For the three and nine months ended September 28, 2019, royalty fees were $6 million and $20 million, respectively.

Other Matters

The Company is subject to lawsuits, investigations and disputes arising out of the conduct of its business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee matters, intellectual property, and environmental, health and safety matters. The Company recognizes a liability for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. No such matters are material to the Company's unaudited financial statements.

The Company, the Company’s former CEO Michael Nefkens, the Company’s former CFO Joseph Ragan, and the Company’s former CIO Niccolo de Masi are named defendants of a class action securities suit in the District court for the District of Minnesota styled In re Resideo Technologies, Inc. Securities Litigation, 19-cv-02863 (the “Securities Litigation”). The Securities Litigation is a class action securities suit with the class defined as all persons or entities who purchased or otherwise acquired common stock of Resideo during the class period of October 29, 2018 to November 6, 2019. The complaint asserts claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, broadly alleging, among other things, that the defendants (or some of them) made false and misleading statements regarding, among other things, Resideo’s business, performance, the efficiency of its supply chain, operational and administrative issues resulting from the spin-off from Honeywell, certain business initiatives, and financial guidance in 2019. The defendants filed a motion to dismiss the complaint on July 10, 2020. We expect the motion to dismiss to be fully briefed in November 2020. A hearing on the motion to dismiss is currently scheduled for December 1, 2020. See “Note 19. Commitments and Contingencies” of Notes to Consolidated and Combined Financial Statements in our 2019 Annual Report on Form 10-K for further discussion. The Company intends to vigorously defend against the allegations in the Securities Litigation, but there can be no assurance that the defense will be successful.

On July 7, 2020, Jawad A. Ayaz as Trustee of the Shiv Venkatasetty 2016 Trust (“Derivative Plaintiff”) filed a shareholder derivative complaint (the “Derivative Complaint”) against certain current or former directors and officers of the Company (“Derivative Defendants”) in the District Court for the District of Delaware, captioned Ayaz v. Nefkens, 20-cv-00915. Derivative Plaintiff alleges generally that Derivative Defendants breached fiduciary duties owed to the Company by allegedly causing or allowing the Company to make materially false and misleading statements to the public regarding the Company’s business operations and financial prospects. Derivative Plaintiff also alleges that the Company’s 2019 proxy statement was materially false and misleading, in violation of Section 14(a) of the Securities Exchange Act of 1934, and asserts claims of corporate waste and unjust enrichment, among other allegations, and relies on a similar set of facts as alleged in the Securities Litigation. The Derivative Complaint seeks declaratory relief and unspecified money damages on behalf of the Company. On July 28, 2020, certain of the Derivative Defendants filed a stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation. An additional shareholder derivative complaint was filed on August 12, 2020, by Plaintiff Daniel Sanclemente (the “Sanclemente Action”) on behalf of the Company in the District Court for the District of Delaware, captioned Sanclemente v. Nefkens, 20-cv-1062, alleging substantially the same facts and making substantially the same claims against the same defendants as in the Derivative Complaint. The District Court has consolidated the Derivative Complaint and the Sanclemente Action. The consolidated action is styled In re Resideo Technologies, Inc. Derivative Litigation, 20-cv-00915 (the “Derivative Action”), and lead counsel has been appointed. Additionally, the pending stipulation to stay the proceedings pending the resolution of the motion to dismiss in the Securities Litigation was granted and is applicable to the consolidated action. On August 28, 2020, Riviera Beach Police Pension Fund (“Riviera Beach”) filed a motion to intervene in the Derivative Action, noticing its intent to file a complaint at some point in the future against some or all of the Derivative Defendants. As of September 18, 2020, Riviera Beach and the existing plaintiffs reached an agreement regarding the leadership structure of the Derivative Action in the event that Riviera Beach files its own complaint in the future. The Company intends to defend this action vigorously, but there can be no assurance that the defense will be successful.

Warranties and Guarantees

In the normal course of business, the Company issues product warranties and product performance guarantees. It accrues for the estimated cost of product warranties and product performance guarantees based on contract terms and historical experience at the time of sale. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. Product warranties and product performance guarantees are included in Accrued liabilities.

The following table summarizes information concerning recorded obligations for product warranties and product performance guarantees:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning of period	$	25		$	26
Accruals for warranties/guarantees issued during the year		13			10
Adjustment of pre-existing warranties/guarantees		-			(1	)
Settlement of warranty/guarantee claims		(12	)		(12	)
End of period	$	26		$	23

XML

Pension

9 Months Ended

Sep. 26, 2020

Compensation And Retirement Disclosure [Abstract]

Pension

Note 14. Pension

The Company sponsors multiple funded and unfunded U.S. and non-U.S. defined benefit pension plans. Pension benefits for many of its U.S. employees are provided through non-contributory, qualified and non-qualified defined benefit plans. It also sponsors defined benefit pension plans which cover non-U.S. employees who are not U.S. citizens, in certain jurisdictions, principally Germany, Austria, Belgium, France, India, Switzerland, and the Netherlands. The pension obligations as of September 26, 2020 and December 31, 2019 were $135 million and $124 million, respectively, and are included in Other liabilities in the unaudited Consolidated Interim Balance Sheets. Net periodic benefit cost recognized in Comprehensive income (loss) for the three and nine months ended September 26, 2020 is $2 million and $6 million, respectively. Net periodic benefit cost recognized in Comprehensive income (loss) for the three and nine months ended September 28, 2019 was $2 million and $5 million, respectively.

The components of net periodic benefit costs other than the service cost are included in Other expense, net in the unaudited Consolidated Interim Statements of Operations for the three and nine months ended September 26, 2020 and September 28, 2019.

XML

Segment Financial Data

9 Months Ended

Sep. 26, 2020

Segment Reporting [Abstract]

Segment Financial Data

Note 15. Segment Financial Data

The Company globally manages its business operations through two reportable operating segments, Products & Solutions and ADI Global Distribution:

Products & Solutions—The Products & Solutions business is a leading global provider of products, software solutions and technologies that help homeowners stay connected and in control of their comfort, security and energy use.

ADI Global Distribution—The ADI Global Distribution business is a leading global distributor of low-voltage electronic and security products.

Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance.

The Company’s Chief Operating Decision Maker evaluates segment performance based on Segment Adjusted EBITDA. Segment Adjusted EBITDA is defined as segment net income (loss) before income taxes, net interest expense (income), depreciation and amortization plus environmental expense, Reimbursement Agreement expense, stock compensation expense, restructuring charges and other adjustments.

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Revenue
Total Products & Solutions revenue	$	674	$	595	$	1,715	$	1,828
Less: Intersegment revenue		102		83		270		228
External Products & Solutions revenue		572		512		1,445		1,600
External ADI Global Distribution revenue		790		714		2,125		2,084
Total revenue	$	1,362	$	1,226	$	3,570	$	3,684

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Segment Adjusted EBITDA
Products & Solutions	$	136	$	66	$	224	$	222
ADI Global Distribution		52		48		126		141
Segment Adjusted EBITDA	$	188	$	114	$	350	$	363

The table below provides a reconciliation of net income (loss) to Segment Adjusted EBITDA:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Net interest expense (1)		14		16		48			49
Tax expense		7		-		26			36
Depreciation and amortization		22		19		64			55
Reimbursement Agreement expense (2)		38		35		107			57
Stock compensation expense (3)		7		8		21			22
Restructuring charges		7		9		27			34
Other (4)		18		19		79			65
Segment Adjusted EBITDA	$	188	$	114	$	350		$	363

(1) For the three and nine months ended September 26, 2020 net interest expense consists of interest expense of $14 million and $49 million net of interest income of $0 million and $1 million, respectively. For the three and nine months ended September 28, 2019 net interest expense consists of interest expense of $16 million and $51 million net of interest income of $0 million and $2 million, respectively.

(2) Represents recorded net expenses related to the Reimbursement Agreement. 

(3) Stock compensation expense adjustment includes only non-cash expenses.

(4) For the three and nine months ended September 26, 2020, Other represents $9 million and $36 million of items related to the Spin-Off, $12 million and $41 million of consulting and other fees related to transformation programs, ($3) million and $1 million of non-operating (income) expense adjustment which excludes net interest (income), and $0 million and $1 million of acquisition-related expenses, respectively. For the three and nine months ended September 28, 2019, Other represents $19 million and $53 million of cost directly related to the Spin-Off, $0 million and $13 million related to developments on legal claims that arose prior to Spin-Off, and $0 million and ($1) million in non-operating (income) expense adjustment which excludes net interest (income), respectively.

The Company’s CODM does not use segment assets information to allocate resources or to assess performance of the segments and therefore, total segment assets have not been disclosed.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 26, 2020

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates—The preparation of the Company’s Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the Consolidated Financial Statements and related disclosures in the accompanying Notes to Consolidated Financial Statements. Actual results could differ from those estimates. Estimates and assumptions are periodically reviewed, and the effects of changes are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Estimates are used when accounting for stock-based compensation, pension benefits, contingent consideration, indemnification liabilities, goodwill and intangible assets, and valuation allowances for accounts receivable, inventory, deferred tax assets, and the amounts of revenue and expenses reported during the period. The Company has used information available to identify potential impacts caused by the COVID-19 pandemic at September 26, 2020 in these estimates.

Goodwill

Goodwill— The Company has determined that it is likely that the carrying value of goodwill exceeds the fair value at September 26, 2020. However, the extent to which COVID-19 may adversely impact our business depends on future developments, which are uncertain and unpredictable, depending upon the severity and duration of the outbreak, and the effectiveness of actions taken globally to contain or mitigate its effects. Any resulting financial impact cannot be estimated reasonably at this time but may adversely affect our business and financial results. It is likely that, during the remainder of 2020 and into 2021, macroeconomic conditions will be volatile and could impact our business. If there is an adverse change in facts and circumstances, then an impairment charge may be necessary in the future. Specifically, the fair value of our Products & Solutions reporting unit, with goodwill of approximately $2,012 million at September 26, 2020, exceeded its' carrying value by 10% in the 2019 annual impairment test and therefore is highly sensitive to adverse changes in the facts and circumstances that could result in a possible future impairment. Should the fair value of the Company’s reporting units fall below its' carrying amount because of reduced operating performance, market declines, changes in the discount rate, a more significant impact than expected from the COVID-19 pandemic, or other conditions, charges for impairment may be necessary. The Company regularly monitors its reporting units to determine if there is an indicator of potential impairment. The Company will perform its annual goodwill impairment assessment during the fourth quarter.

Recent Accounting Pronouncements

Recent Accounting Pronouncements—The Company considers the applicability and impact of all recent accounting standards updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s consolidated financial position or results of operations.

In August 2018, the FASB issued guidance that amends the current disclosure requirements regarding defined benefit pensions and other post retirement plans and allows for the removal of certain disclosures, while adding certain new disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2020 and allows for early adoption. The Company will adopt on January 1, 2021 and does not expect this new standard to have a significant impact to its disclosures.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by, among other things, eliminating certain existing exceptions related to the general approach in ASC 740 relating to franchise taxes, reducing complexity in

the interim-period accounting for year-to-date loss limitations and changes in tax laws, and clarifying the accounting for transactions outside of business combinations that result in a step-up in the tax basis of goodwill. The transition requirements are primarily prospective and the effective date for Resideo is January 1, 2021, with early adoption permitted. The Company early adopted the provisions of this guidance on January 1, 2020. Adoption of this guidance did not have a material financial statement impact.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which is optional guidance related to reference rate reform that provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our Term Loans and Revolving Credit Facility, which use LIBOR as a reference rate, and is effective immediately, but is only available through December 31, 2022. Refer to “Note 10. Long-term Debt and Credit Agreement” for further details on our Term Loans and Revolving Credit Facility. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

XML

Earnings (Loss) Per Share (Tables)

9 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in millions except shares in thousands and per share data):

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Shares used in computing basic earnings per share		123,421		122,770		123,194			122,681
Effect of dilutive securities:
Dilutive effect of common stock equivalents		1,814		474		-			723
Shares used in computing diluted earnings per share		125,235		123,244		123,194			123,404
Earnings (loss) per share:
Basic	$	0.61	$	0.07	$	(0.18	)	$	0.37
Diluted	$	0.60	$	0.06	$	(0.18	)	$	0.36

XML

Revenue Recognition (Tables)

9 Months Ended

Sep. 26, 2020

Revenue From Contract With Customer [Abstract]

Schedule of Disaggregated Revenue

Revenues by geography and business line are as follows:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Comfort	$	297	$	256	$	725	$	799
Security		142		128		379		397
Residential Thermal Solutions		133		128		341		404
Products & Solutions		572		512		1,445		1,600
U.S. and Canada		650		590		1,758		1,705
EMEA (1)		129		109		338		336
APAC (2)		11		15		29		43
ADI Global Distribution		790		714		2,125		2,084
Net revenue	$	1,362	$	1,226	$	3,570	$	3,684

(1) EMEA represents Europe, the Middle East and Africa.

(2) APAC represents Asia and Pacific countries.

XML

Restructuring and Other Charges (Tables)

9 Months Ended

Sep. 26, 2020

Restructuring And Related Activities [Abstract]

Summary of Restructuring Expenses

The Company's restructuring expenses for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	2	$	4	$	7	$	11
Selling, general and administrative expenses		5		5		20		23
	$	7	$	9	$	27	$	34

Summary of Status of Total Restructuring Reserves Related to Severance Cost Included in Accrued Liabilities in the Unaudited Consolidated Balance Sheets

The following table summarizes the status of total restructuring reserves related to severance cost included in Accrued liabilities in the unaudited Consolidated Balance Sheets: 

	Nine Months Ended
	September 26,
	2020
Beginning of period	$	19
Charges		27
Usage – cash payments		(23	)
End of period	$	23

XML

Inventories Net (Tables)

9 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

Inventories

	September 26,			December 31,
	2020			2019
Raw materials	$	156		$	154
Work in process		20			18
Finished products		521			568
Inventory reserves		(79	)		(69	)
	$	618		$	671

XML

Accrued Liabilities (Tables)

9 Months Ended

Sep. 26, 2020

Payables And Accruals [Abstract]

Summary of Accrued Liabilities

	September 26,		December 31,
	2020		2019
Obligations payable under Indemnification Agreements	$	175	$	140
Taxes payable		53		66
Compensation, benefit and other employee-related		82		66
Customer rebate reserve		71		78
Other		225		202
	$	606	$	552

XML

Long-term Debt and Credit Agreement (Tables)

9 Months Ended

Sep. 26, 2020

Debt Disclosure [Abstract]

Schedule of Debt

The Company’s debt at September 26, 2020 and December 31, 2019 consisted of the following:

	September 26,			December 31,
	2020			2019
6.125% notes due 2026	$	400		$	400
Five-year variable rate term loan A due 2023		324			333
Seven-year variable rate term loan B due 2025		468			470
Revolving Credit Facility		150			-
Unamortized deferred financing costs and debt discounts		(20	)		(23	)
Total outstanding indebtedness		1,322			1,180
Less: amounts due within one year		181			22
Total long-term debt due after one year	$	1,141		$	1,158

XML

Leases (Tables)

9 Months Ended

Sep. 26, 2020

Leases [Abstract]

Schedule of Operating Lease Costs

The Company’s operating lease costs for the three and nine months ended September 26, 2020 and September 28, 2019 consisted of the following:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Cost of goods sold	$	5	$	4	$	13	$	12
Selling, general & administrative		13		10		33		27
Total operating lease costs	$	18	$	14	$	46	$	39

Summary of Lease Recognized Related to Operating Leases

The Company recognized the following related to its operating leases:

	Financial Statement Line Item	At September 26, 2020		At December 31, 2019
Operating right-of-use assets	Other assets	$	134	$	137
Operating lease liabilities - current	Accrued liabilities	$	33	$	31
Operating lease liabilities - noncurrent	Other liabilities	$	109	$	111

Maturities of Operating Lease Liabilities

Maturities of the Company’s operating lease liabilities were as follows:

	At September 26, 2020
2020	$	10
2021		39
2022		35
2023		28
2024		16
Thereafter		39
Total lease payments		167
Less: imputed interest		25
Present value of operating lease liabilities	$	142
Weighted-average remaining lease term (years)		5.44
Weighted-average incremental borrowing rate		6.00	%

Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to the Company’s operating leases was as follows:

	Nine Months Ended
	September 26,		September 28,
	2020		2019
Operating cash outflows	$	22	$	28
Operating right-of-use assets obtained in exchange for operating lease liabilities	$	22	$	47

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 26, 2020

Loss Contingencies [Line Items]

Summary of Recorded Obligations for Product Warranties and Product Performance Guarantee

The following table summarizes information concerning recorded obligations for product warranties and product performance guarantees:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning of period	$	25		$	26
Accruals for warranties/guarantees issued during the year		13			10
Adjustment of pre-existing warranties/guarantees		-			(1	)
Settlement of warranty/guarantee claims		(12	)		(12	)
End of period	$	26		$	23

Honeywell

Loss Contingencies [Line Items]

Summary of Reimbursement Agreement Liabilities

The following table summarizes information concerning our Reimbursement Agreement liabilities:

	Nine Months Ended
	September 26,			September 28,
	2020			2019
Beginning balance	$	585		$	616
Accruals for indemnification liabilities deemed probable and reasonably estimable		107			138
Reduction (1)		-			(81	)
Indemnification payment		(70	)		(105	)
Ending balance (2)	$	622		$	568

(1) Reduction in indemnification liabilities relates to a provision in the Reimbursement Agreement that reduces the obligation due to Honeywell for any proceeds received by Honeywell from a property sale of a site under the agreement.

(2) Reimbursement Agreement liabilities deemed probable and reasonably estimable, however, it is possible the Company could pay $140 million per year (exclusive of any late payment fees up to 5% per annum) until the earlier of (1) December 31, 2043; or (2) December 31 of the third consecutive year during which the annual reimbursement obligation (including in respect of deferred payment amounts) has been less than $25 million.

Summary of Reimbursement Agreement Liabilities Included in Balance Sheet Accounts

Reimbursement Agreement liabilities are included in the following balance sheet accounts:

	September 26, 2020		December 31, 2019
Accrued liabilities	$	175	$	140
Obligations payable under Indemnification Agreements		447		445
	$	622	$	585

XML

Segment Financial Data (Tables)

9 Months Ended

Sep. 26, 2020

Segment Reporting [Abstract]

Schedule of Segment Information

Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance.

The Company’s Chief Operating Decision Maker evaluates segment performance based on Segment Adjusted EBITDA. Segment Adjusted EBITDA is defined as segment net income (loss) before income taxes, net interest expense (income), depreciation and amortization plus environmental expense, Reimbursement Agreement expense, stock compensation expense, restructuring charges and other adjustments.

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Revenue
Total Products & Solutions revenue	$	674	$	595	$	1,715	$	1,828
Less: Intersegment revenue		102		83		270		228
External Products & Solutions revenue		572		512		1,445		1,600
External ADI Global Distribution revenue		790		714		2,125		2,084
Total revenue	$	1,362	$	1,226	$	3,570	$	3,684

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
	2020		2019		2020		2019
Segment Adjusted EBITDA
Products & Solutions	$	136	$	66	$	224	$	222
ADI Global Distribution		52		48		126		141
Segment Adjusted EBITDA	$	188	$	114	$	350	$	363

Schedule of Reconciliation of Adjusted EBITDA

The table below provides a reconciliation of net income (loss) to Segment Adjusted EBITDA:

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,			September 28,
	2020		2019		2020			2019
Net income (loss)	$	75	$	8	$	(22	)	$	45
Net interest expense (1)		14		16		48			49
Tax expense		7		-		26			36
Depreciation and amortization		22		19		64			55
Reimbursement Agreement expense (2)		38		35		107			57
Stock compensation expense (3)		7		8		21			22
Restructuring charges		7		9		27			34
Other (4)		18		19		79			65
Segment Adjusted EBITDA	$	188	$	114	$	350		$	363

(1) For the three and nine months ended September 26, 2020 net interest expense consists of interest expense of $14 million and $49 million net of interest income of $0 million and $1 million, respectively. For the three and nine months ended September 28, 2019 net interest expense consists of interest expense of $16 million and $51 million net of interest income of $0 million and $2 million, respectively.

(2) Represents recorded net expenses related to the Reimbursement Agreement. 

(3) Stock compensation expense adjustment includes only non-cash expenses.

(4) For the three and nine months ended September 26, 2020, Other represents $9 million and $36 million of items related to the Spin-Off, $12 million and $41 million of consulting and other fees related to transformation programs, ($3) million and $1 million of non-operating (income) expense adjustment which excludes net interest (income), and $0 million and $1 million of acquisition-related expenses, respectively. For the three and nine months ended September 28, 2019, Other represents $19 million and $53 million of cost directly related to the Spin-Off, $0 million and $13 million related to developments on legal claims that arose prior to Spin-Off, and $0 million and ($1) million in non-operating (income) expense adjustment which excludes net interest (income), respectively.

XML

Organization, Operations and Basis of Presentation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Date of business spin-off			Oct. 29, 2018
Cost of goods sold	$ 992	$ 917	$ 2,680	$ 2,720
Gross profit	370	309	890	964
Selling, general and administrative expenses	$ 239	250	$ 731	778
Restatement Adjustment
Cost of goods sold		(20)		(66)
Gross profit		20		66
Selling, general and administrative expenses		$ 20		$ 66

XML

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Goodwill	$ 2,657	$ 2,642
Products & Solutions Reporting Unit
Summary Of Significant Accounting Policies [Line Items]
Goodwill	$ 2,012
Goodwill percentage of fair value in excess of carrying value	10.00%

XML

Earnings (Loss) Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Earnings Per Share [Abstract]
Net income (loss)	$ 75	$ 8	$ (22)	$ 45
Shares used in computing basic earnings per share	123,421	122,770	123,194	122,681
Effect of dilutive securities:
Dilutive effect of common stock equivalents	1,814	474		723
Shares used in computing diluted earnings per share	125,235	123,244	123,194	123,404
Earnings (loss) per share:
Basic	$ 0.61	$ 0.07	$ (0.18)	$ 0.37
Diluted	$ 0.60	$ 0.06	$ (0.18)	$ 0.36

XML

Earnings (Loss) Per Share - Additional Information (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Earnings Per Share [Line Items]
Purchase of outstanding common stock were anti-dilutive	0	0	0	0
Options and Other Rights
Earnings Per Share [Line Items]
Purchase of outstanding common stock were anti-dilutive	1,100	3,800	3,600	1,500
Performance Based Unit Awards
Earnings Per Share [Line Items]
Purchase of outstanding common stock were anti-dilutive	800	300	600	300

XML

Acquisitions - Additional Information (Details) - USD ($) $ in Millions		9 Months Ended
	Feb. 10, 2020	Sep. 26, 2020	Sep. 28, 2019	Dec. 31, 2019
Business Acquisition [Line Items]
Business acquisition		$ 35	$ 17
Goodwill		$ 2,657		$ 2,642
Herman ProAV
Business Acquisition [Line Items]
Business acquisition	$ 36
Goodwill	4
Business acquisition, intangible assets acquired	$ 18

XML

Revenue Recognition - Schedule of Disaggregated Revenue (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Disaggregation Of Revenue [Line Items]
Revenue		$ 1,362	$ 1,226	$ 3,570	$ 3,684
Products & Solutions
Disaggregation Of Revenue [Line Items]
Revenue		572	512	1,445	1,600
Products & Solutions | Comfort
Disaggregation Of Revenue [Line Items]
Revenue		297	256	725	799
Products & Solutions | Security
Disaggregation Of Revenue [Line Items]
Revenue		142	128	379	397
Products & Solutions | Residential Thermal Solutions
Disaggregation Of Revenue [Line Items]
Revenue		133	128	341	404
ADI Global Distribution
Disaggregation Of Revenue [Line Items]
Revenue		790	714	2,125	2,084
ADI Global Distribution | U.S. and Canada
Disaggregation Of Revenue [Line Items]
Revenue		650	590	1,758	1,705
ADI Global Distribution | EMEA
Disaggregation Of Revenue [Line Items]
Revenue	[1]	129	109	338	336
ADI Global Distribution | APAC
Disaggregation Of Revenue [Line Items]
Revenue	[2]	$ 11	$ 15	$ 29	$ 43

[1] EMEA represents Europe, the Middle East and Africa.

[2] APAC represents Asia and Pacific countries.

XML

Revenue Recognition - Additional Information (Details)	Sep. 26, 2020
Restructuring And Related Activities [Abstract]
Percentage of revenue satisfied over time	3.00%

XML

Restructuring and Other Charges - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Restructuring Cost And Reserve [Line Items]
Restructuring and related expenses	$ 7	$ 9	$ 27	$ 34
Severance | Products & Solutions
Restructuring Cost And Reserve [Line Items]
Restructuring and related expenses	7	9	24	28
Severance | ADI Global Distribution
Restructuring Cost And Reserve [Line Items]
Restructuring and related expenses	$ 0	$ 0	$ 3	$ 6

XML

Restructuring and Other Charges - Summary of Restructuring Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 7	$ 9	$ 27	$ 34
Cost of Goods Sold
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	2	4	7	11
Selling, General and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 5	$ 5	$ 20	$ 23

XML

Restructuring and Other Charges - Summary of Status of Total Restructuring Reserves Related to Severance Cost Included in Accrued Liabilities in the Unaudited Consolidated Balance Sheets (Details) - Accrued Liabilities $ in Millions	9 Months Ended
	Sep. 26, 2020 USD ($)
Restructuring Cost And Reserve [Line Items]
Beginning of period	$ 19
Charges	27
Usage – cash payments	(23)
End of period	$ 23

XML

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 26, 2020	Sep. 26, 2020	Sep. 28, 2019
Income Tax Disclosure [Abstract]
Tax expense	$ 7	$ 26	$ 36
Interim period tax expense (benefit)	7	11
Tax expense (benefit)	$ 0	15
Valuation allowance		15
Estimated tax impact of CARES Act		2
Tax expense for share-based excess cost		1
Tax benefit for changes in estimates related to prior years		$ 3

XML

Inventories Net (Details) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 156	$ 154
Work in process	20	18
Finished products	521	568
Inventory reserves	(79)	(69)
Inventory, Net	$ 618	$ 671

XML

Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Accrued Liabilities, Current [Abstract]
Obligations payable under Indemnification Agreements	$ 175	$ 140
Taxes payable	53	66
Compensation, benefit and other employee-related	82	66
Customer rebate reserve	71	78
Other	225	202
Total accrued liabilities	$ 606	$ 552

XML

Long-term Debt and Credit Agreement - Schedule of Debt (Details) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Unamortized deferred financing costs and debt discounts	$ (20)	$ (23)
Total outstanding indebtedness	1,322	1,180
Less: amounts due within one year	181	22
Total long-term debt due after one year	1,141	1,158
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving Credit Facility	150
6.125% notes due 2026
Debt Instrument [Line Items]
Long-term debt, gross	400	400
Five Year Variable Rate Term Loan A Due 2023
Debt Instrument [Line Items]
Long-term debt, gross	324	333
Seven Year Variable Rate Term Loan B Due 2025
Debt Instrument [Line Items]
Long-term debt, gross	$ 468	$ 470

XML

Long-term Debt and Credit Agreement - Schedule of Debt (Parenthetical) (Details)		9 Months Ended
	Nov. 26, 2019	Sep. 26, 2020
6.125% notes due 2026
Debt Instrument [Line Items]
Interest rate		6.125%
Debt instrument maturity year		2026
Five Year Variable Rate Term Loan A Due 2023
Debt Instrument [Line Items]
Debt instrument maturity year	2023	2023
Seven Year Variable Rate Term Loan B Due 2025
Debt Instrument [Line Items]
Debt instrument maturity year	2025	2025

XML

Long-term Debt and Credit Agreement - Additional Information (Details) $ in Millions		3 Months Ended				9 Months Ended
	Nov. 26, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Sep. 26, 2020 USD ($)
Five Year Variable Rate Term Loan A Due 2023
Debt Instrument [Line Items]
Debt instrument maturity year	2023					2023
Seven Year Variable Rate Term Loan B Due 2025
Debt Instrument [Line Items]
Debt instrument maturity year	2025					2025
6.125% notes due 2026
Debt Instrument [Line Items]
Debt instrument maturity year						2026
Interest rate						6.125%
Senior Notes
Debt Instrument [Line Items]
Debt Instrument fair value						$ 395
Credit Agreement Amendment
Debt Instrument [Line Items]
Consolidated total leverage ratio					525.00%
Increase in applicable interest rate margin	0.0025
Credit Agreement Amendment | London Interbank Offered Rate LIBOR
Debt Instrument [Line Items]
Applicable interest rate on borrowings	2.25%
Credit Agreement Amendment | Base Rate
Debt Instrument [Line Items]
Applicable interest rate on borrowings	1.25%
Credit Agreement Amendment | Term B Loan Facility | London Interbank Offered Rate LIBOR | Maximum
Debt Instrument [Line Items]
Applicable interest rate on borrowings	2.25%
Credit Agreement Amendment | Term B Loan Facility | Base Rate | Minimum
Debt Instrument [Line Items]
Applicable interest rate on borrowings	1.75%
Credit Agreement Amendment | Term A Loan Facility | London Interbank Offered Rate LIBOR | Maximum
Debt Instrument [Line Items]
Applicable interest rate on borrowings	1.25%
Credit Agreement Amendment | Term A Loan Facility | Base Rate | Minimum
Debt Instrument [Line Items]
Applicable interest rate on borrowings	0.75%
Credit Agreement Amendment | Scenario Forecast
Debt Instrument [Line Items]
Consolidated total leverage ratio		375.00%	425.00%	475.00%
Term A Loan Facility | Senior Credit Facilities
Debt Instrument [Line Items]
Debt Instrument fair value						307
Term B Loan Facility | Senior Credit Facilities
Debt Instrument [Line Items]
Debt Instrument fair value						460
Revolving Credit Facility
Debt Instrument [Line Items]
Borrowings from credit facility						150
Revolving Credit Facility | Senior Credit Facilities
Debt Instrument [Line Items]
Borrowings from credit facility						$ 150
Weighted average interest rate						2.41%
Letter of Credit | Senior Credit Facilities
Debt Instrument [Line Items]
Borrowings from credit facility						$ 0
Term Loan Facilities | Senior Credit Facilities
Debt Instrument [Line Items]
Interest rate						2.56%

XML

Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Lessee Lease Description [Line Items]
Total operating lease costs	$ 18	$ 14	$ 46	$ 39
Cost of Goods Sold
Lessee Lease Description [Line Items]
Total operating lease costs	5	4	13	12
Selling, General and Administrative Expenses
Lessee Lease Description [Line Items]
Total operating lease costs	$ 13	$ 10	$ 33	$ 27

XML

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Leases [Abstract]
Variable lease costs	$ 5	$ 3	$ 12	$ 8

XML

Leases - Summary of Lease Recognized Related to Operating Leases (Details) - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019
Leases [Abstract]
Operating right-of-use assets	$ 134	$ 137
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Operating lease liabilities - current	$ 33	$ 31
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent	us-gaap:AccruedLiabilitiesCurrent
Operating lease liabilities - noncurrent	$ 109	$ 111
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilitiesNoncurrent	us-gaap:OtherLiabilitiesNoncurrent

XML

Leases - Maturities of Operating Lease Liabilities (Details) $ in Millions	Sep. 26, 2020 USD ($)
Leases [Abstract]
2020	$ 10
2021	39
2022	35
2023	28
2024	16
Thereafter	39
Total lease payments	167
Less: imputed interest	25
Present value of operating lease liabilities	$ 142
Weighted-average remaining lease term (years)	5 years 5 months 8 days
Weighted-average incremental borrowing rate	6.00%

XML

Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Leases [Abstract]
Operating cash outflows	$ 22	$ 28
Operating right-of-use assets obtained in exchange for operating lease liabilities	$ 22	$ 47

XML

Stock-Based Compensation Plans - Additional Information (Details) - 2018 Stock Incentive Plan	9 Months Ended
	Sep. 26, 2020 $ / shares shares
Performance-Based Restricted Stock Units | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted | shares	795,099
Time Based Restricted Stock Units | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted | shares	2,168,943
Performance-Based and Service Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value | $ / shares	$ 9.18
Stock Options | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted | shares	1,083,665
Weighted average exercise price per share | $ / shares	$ 9.17
Weighted average grant date fair value per share | $ / shares	$ 2.61

XML

Commitments and Contingencies - Additional Information (Details)					3 Months Ended		9 Months Ended
		Jul. 28, 2020 USD ($)	Apr. 30, 2020 USD ($)	Oct. 29, 2018 USD ($) Site	Sep. 26, 2020 USD ($)	Sep. 28, 2019 USD ($)	Sep. 26, 2020 USD ($)	Sep. 28, 2019 USD ($)	Dec. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Environmental liabilities					$ 22,000,000		$ 22,000,000		$ 22,000,000
Reimbursement agreement net expenses	[1]				38,000,000	$ 35,000,000	$ 107,000,000	$ 57,000,000
Trademark license agreement							40 years
Other Expense, Net
Loss Contingencies [Line Items]
Reimbursement agreement net expenses					38,000,000	35,000,000	$ 107,000,000	57,000,000
Credit Agreement Amendment
Loss Contingencies [Line Items]
Indemnification payment defer			$ 35,000,000
Indemnification Agreement
Loss Contingencies [Line Items]
Indemnification payable, late payment fee percentage				5.00%
Site contingency, number of sites | Site				230
Indemnification agreement description							On October 29, 2018, in connection with the Spin-Off, the Company entered into the Reimbursement Agreement with Honeywell pursuant to which the Company has an obligation to make cash payments to Honeywell in amounts equal to 90% of payments for certain Honeywell environmental-liability payments, which include amounts billed (“payments”), less 90% of Honeywell’s net insurance receipts relating to such liabilities, and less 90% of the net proceeds received by Honeywell in connection with (i) affirmative claims relating to such liabilities, (ii) contributions by other parties relating to such liabilities and (iii) certain property sales (the “recoveries”). The amount payable by the Company in respect of such liabilities arising in respect of any given year is subject to a cap of $140 million (exclusive of any late payment fees up to 5% per annum). The scope of the Company’s current environmental remediation obligations subject to the Reimbursement Agreement relates to approximately 230 sites or groups of sites that are undergoing environmental remediation under U.S. federal or state law and agency oversight for contamination associated with Honeywell historical business operations. The ongoing environmental remediation is designed to address contaminants at upland and sediment sites, which include, among others, metals, organic compounds and polychlorinated biphenyls, through a variety of methods, which include, among others, excavation, capping, in-situ stabilization, groundwater treatment and dredging. In addition, the Company obligations subject to the Reimbursement Agreement include certain liabilities with respect to (i) hazardous exposure or toxic tort claims associated with the specified sites that arise after the Spin-Off, if any, (ii) currently unidentified releases of hazardous substances at or associated with the specified sites, (iii) other environmental claims associated with the specified sites and (iv) consequential damages.
Maximum annual reimbursement obligation amount					25,000,000		$ 25,000,000
Indemnification Agreement | Maximum
Loss Contingencies [Line Items]
Indemnity liability annual cap				$ 140,000,000
Tax Matters Agreement
Loss Contingencies [Line Items]
Indemnified amount					139,000,000		139,000,000		$ 149,000,000
Honeywell
Loss Contingencies [Line Items]
Indemnity liability annual cap					$ 140,000,000	140,000,000	$ 140,000,000	140,000,000
Honeywell | Second Reimbursement Agreement Amendment
Loss Contingencies [Line Items]
Reimbursement obligation quarterly payment		$ 35,000,000
Reimbursement obligation quarterly payment description		Pursuant to the Second Reimbursement Agreement Amendment, the parties agreed to further defer until no later than October 30, 2020 the $35 million quarterly payment that was originally due thirty days following the start of the second quarter of 2020 and was previously deferred until no later than July 30, 2020 pursuant to the Reimbursement Agreement Amendment. The deferred payment was made on October 30, 2020.
Honeywell | Trademark Agreement
Loss Contingencies [Line Items]
Royalty fee on net revenue					1.50%		1.50%
Royalty expense					$ 7,000,000	6,000,000	$ 18,000,000	$ 20,000,000
Honeywell | Maximum
Loss Contingencies [Line Items]
Indemnification payable, late payment fee percentage							5.00%	5.00%
Maximum annual reimbursement obligation amount					$ 25,000,000	$ 25,000,000	$ 25,000,000	$ 25,000,000
Honeywell | Indemnification Agreement
Loss Contingencies [Line Items]
Indemnification payable percentage of payments				90.00%
Indemnification payable percentage of net insurance receipts				90.00%
Indemnification payable percentage of net proceeds received				90.00%

[1] Represents recorded net expenses related to the Reimbursement Agreement.

XML

Commitments and Contingencies - Summary of Reimbursement Agreement Liabilities (Details) - Honeywell - USD ($) $ in Millions	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Accrual for Reimbursement Agreement
Beginning balance	$ 585	$ 616
Accruals for indemnification liabilities deemed probable and reasonably estimable	107	138
Reduction		(81)
Indemnification payment	(70)	(105)
Ending balance	$ 622	$ 568

XML

Commitments and Contingencies - Summary of Reimbursement Agreement Liabilities (Parenthetical) (Details) - Honeywell - USD ($)	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Loss Contingencies [Line Items]
Indemnity liability annual cap	$ 140,000,000	$ 140,000,000
Maximum
Loss Contingencies [Line Items]
Indemnification payable, late payment fee percentage	5.00%	5.00%
Maximum annual reimbursement obligation amount	$ 25,000,000	$ 25,000,000

XML

Commitments and Contingencies - Summary of Reimbursement Agreement Liabilities Included in Balance Sheet Accounts (Details) - Honeywell - USD ($) $ in Millions	Sep. 26, 2020	Dec. 31, 2019	Sep. 28, 2019	Dec. 31, 2018
Loss Contingency, Classification of Accrual [Abstract]
Reimbursement Agreement liabilities	$ 622	$ 585	$ 568	$ 616
Accrued Liabilities
Loss Contingency, Classification of Accrual [Abstract]
Reimbursement agreement current portion	175	140
Obligations Payable under Indemnification Agreements
Loss Contingency, Classification of Accrual [Abstract]
Reimbursement agreement Long Term Portion	$ 447	$ 445

XML

Commitments and Contingencies - Summary of Recorded Obligations for Product Warranties and Product Performance Guarantee (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Product Warranties and Guarantees [Roll forward]
Beginning of period	$ 25	$ 26
Accruals for warranties/guarantees issued during the year	13	10
Adjustment of pre-existing warranties/guarantees		(1)
Settlement of warranty/guarantee claims	(12)	(12)
End of period	$ 26	$ 23

XML

Pension - Additional Information (Details) - Pension Plans - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Pension obligations	$ 135		$ 135		$ 124
Net periodic benefit cost	$ 2	$ 2	$ 6	$ 5

XML

Segment Financial Data - Additional Information (Details)	9 Months Ended
	Sep. 26, 2020 Segment
Segment Reporting [Abstract]
Number of operating segments	2

XML

Segment Financial Data - Schedule of Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Revenue
Revenue	$ 1,362	$ 1,226	$ 3,570	$ 3,684
Segment Adjusted EBITDA
Total	131	59	159	186
Total	188	114	350	363
Products & Solutions
Revenue
Revenue	572	512	1,445	1,600
Segment Adjusted EBITDA
Total	136	66	224	222
ADI Global Distribution
Revenue
Revenue	790	714	2,125	2,084
Segment Adjusted EBITDA
Total	52	48	126	141
Operating Segments | Products & Solutions
Revenue
Revenue	674	595	1,715	1,828
Intersegment Revenue Eliminations | Products & Solutions
Revenue
Revenue	$ (102)	$ (83)	$ (270)	$ (228)

XML

Segment Financial Data - Schedule of Reconciliation of Segment Adjusted EBITDA (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Segment Reporting [Abstract]
Net income (loss)		$ 75	$ 8	$ (22)	$ 45
Net interest expense	[1]	14	16	48	49
Tax expense		7		26	36
Depreciation and amortization		22	19	64	55
Reimbursement Agreement expense	[2]	38	35	107	57
Stock compensation expense	[3]	7	8	21	22
Restructuring charges		7	9	27	34
Other	[4]	18	19	79	65
Total		$ 188	$ 114	$ 350	$ 363

[1] For the three and nine months ended September 26, 2020 net interest expense consists of interest expense of $14 million and $49 million net of interest income of $0 million and $1 million, respectively. For the three and nine months ended September 28, 2019 net interest expense consists of interest expense of $16 million and $51 million net of interest income of $0 million and $2 million, respectively.

[2] Represents recorded net expenses related to the Reimbursement Agreement.

[3] Stock compensation expense adjustment includes only non-cash expenses.

[4] For the three and nine months ended September 26, 2020, Other represents $9 million and $36 million of items related to the Spin-Off, $12 million and $41 million of consulting and other fees related to transformation programs, ($3) million and $1 million of non-operating (income) expense adjustment which excludes net interest (income), and $0 million and $1 million of acquisition-related expenses, respectively. For the three and nine months ended September 28, 2019, Other represents $19 million and $53 million of cost directly related to the Spin-Off, $0 million and $13 million related to developments on legal claims that arose prior to Spin-Off, and $0 million and ($1) million in non-operating (income) expense adjustment which excludes net interest (income), respectively.

XML

Segment Financial Data - Schedule of Reconciliation of Segment Adjusted EBITDA (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Loss Contingencies [Line Items]
Interest expense	$ 14	$ 16	$ 49	$ 51
Interest income	0	0	1	2
Spin-off costs	7	9	27	34
Consulting and other fees related to transformation programs	12		41
Non-operating (income) expense adjustment	(3)	0	1	(1)
Acquisition-related expenses	0		1
Developments on legal claims prior to spin-off		0		13
Honeywell
Loss Contingencies [Line Items]
Spin-off costs	$ 9	$ 19	$ 36	$ 53